research topics in biotech

200+ Biotechnology Research Topics: Let’s Shape the Future

In the dynamic landscape of scientific exploration, biotechnology stands at the forefront, revolutionizing the way we approach healthcare, agriculture, and environmental sustainability. This interdisciplinary field encompasses a vast array of research topics that hold the potential to reshape our world. 

In this blog post, we will delve into the realm of biotechnology research topics, understanding their significance and exploring the diverse avenues that researchers are actively investigating.

Overview of Biotechnology Research

Table of Contents

Biotechnology, at its core, involves the application of biological systems, organisms, or derivatives to develop technologies and products for the benefit of humanity. 

The scope of biotechnology research is broad, covering areas such as genetic engineering, biomedical engineering, environmental biotechnology, and industrial biotechnology. Its interdisciplinary nature makes it a melting pot of ideas and innovations, pushing the boundaries of what is possible.

How to Select The Best Biotechnology Research Topics?

• Identify Your Interests

Start by reflecting on your own interests within the broad field of biotechnology. What aspects of biotechnology excite you the most? Identifying your passion will make the research process more engaging.

• Stay Informed About Current Trends

Keep up with the latest developments and trends in biotechnology. Subscribe to scientific journals, attend conferences, and follow reputable websites to stay informed about cutting-edge research. This will help you identify gaps in knowledge or areas where advancements are needed.

• Consider Societal Impact

Evaluate the potential societal impact of your chosen research topic. How does it contribute to solving real-world problems? Biotechnology has applications in healthcare, agriculture, environmental conservation, and more. Choose a topic that aligns with the broader goal of improving quality of life or addressing global challenges.

• Assess Feasibility and Resources

Evaluate the feasibility of your research topic. Consider the availability of resources, including laboratory equipment, funding, and expertise. A well-defined and achievable research plan will increase the likelihood of successful outcomes.

• Explore Innovation Opportunities

Look for opportunities to contribute to innovation within the field. Consider topics that push the boundaries of current knowledge, introduce novel methodologies, or explore interdisciplinary approaches. Innovation often leads to groundbreaking discoveries.

• Consult with Mentors and Peers

Seek guidance from mentors, professors, or colleagues who have expertise in biotechnology. Discuss your research interests with them and gather insights. They can provide valuable advice on the feasibility and significance of your chosen topic.

• Balance Specificity and Breadth

Strike a balance between biotechnology research topics that are specific enough to address a particular aspect of biotechnology and broad enough to allow for meaningful research. A topic that is too narrow may limit your research scope, while one that is too broad may lack focus.

• Consider Ethical Implications

Be mindful of the ethical implications of your research. Biotechnology, especially areas like genetic engineering, can raise ethical concerns. Ensure that your chosen topic aligns with ethical standards and consider how your research may impact society.

• Evaluate Industry Relevance

Consider the relevance of your research topic to the biotechnology industry. Industry-relevant research has the potential for practical applications and may attract funding and collaboration opportunities.

• Stay Flexible and Open-Minded

Be open to refining or adjusting your research topic as you delve deeper into the literature and gather more information. Flexibility is key to adapting to new insights and developments in the field.

200+ Biotechnology Research Topics: Category-Wise

Genetic engineering.

• CRISPR-Cas9: Recent Advances and Applications
• Gene Editing for Therapeutic Purposes: Opportunities and Challenges
• Precision Medicine and Personalized Genomic Therapies
• Genome Sequencing Technologies: Current State and Future Prospects
• Synthetic Biology: Engineering New Life Forms
• Genetic Modification of Crops for Improved Yield and Resistance
• Ethical Considerations in Human Genetic Engineering
• Gene Therapy for Neurological Disorders
• Epigenetics: Understanding the Role of Gene Regulation
• CRISPR in Agriculture: Enhancing Crop Traits

Biomedical Engineering

• Tissue Engineering: Creating Organs in the Lab
• 3D Printing in Biomedical Applications
• Advances in Drug Delivery Systems
• Nanotechnology in Medicine: Theranostic Approaches
• Bioinformatics and Computational Biology in Biomedicine
• Wearable Biomedical Devices for Health Monitoring
• Stem Cell Research and Regenerative Medicine
• Precision Oncology: Tailoring Cancer Treatments
• Biomaterials for Biomedical Applications
• Biomechanics in Biomedical Engineering

Environmental Biotechnology

• Bioremediation of Polluted Environments
• Waste-to-Energy Technologies: Turning Trash into Power
• Sustainable Agriculture Practices Using Biotechnology
• Bioaugmentation in Wastewater Treatment
• Microbial Fuel Cells: Harnessing Microorganisms for Energy
• Biotechnology in Conservation Biology
• Phytoremediation: Plants as Environmental Cleanup Agents
• Aquaponics: Integration of Aquaculture and Hydroponics
• Biodiversity Monitoring Using DNA Barcoding
• Algal Biofuels: A Sustainable Energy Source

Industrial Biotechnology

• Enzyme Engineering for Industrial Applications
• Bioprocessing and Bio-manufacturing Innovations
• Industrial Applications of Microbial Biotechnology
• Bio-based Materials: Eco-friendly Alternatives
• Synthetic Biology for Industrial Processes
• Metabolic Engineering for Chemical Production
• Industrial Fermentation: Optimization and Scale-up
• Biocatalysis in Pharmaceutical Industry
• Advanced Bioprocess Monitoring and Control
• Green Chemistry: Sustainable Practices in Industry

Emerging Trends in Biotechnology

• CRISPR-Based Diagnostics: A New Era in Disease Detection
• Neurobiotechnology: Advancements in Brain-Computer Interfaces
• Advances in Nanotechnology for Healthcare
• Computational Biology: Modeling Biological Systems
• Organoids: Miniature Organs for Drug Testing
• Genome Editing in Non-Human Organisms
• Biotechnology and the Internet of Things (IoT)
• Exosome-based Therapeutics: Potential Applications
• Biohybrid Systems: Integrating Living and Artificial Components
• Metagenomics: Exploring Microbial Communities

Ethical and Social Implications

• Ethical Considerations in CRISPR-Based Gene Editing
• Privacy Concerns in Personal Genomic Data Sharing
• Biotechnology and Social Equity: Bridging the Gap
• Dual-Use Dilemmas in Biotechnological Research
• Informed Consent in Genetic Testing and Research
• Accessibility of Biotechnological Therapies: Global Perspectives
• Human Enhancement Technologies: Ethical Perspectives
• Biotechnology and Cultural Perspectives on Genetic Modification
• Social Impact Assessment of Biotechnological Interventions
• Intellectual Property Rights in Biotechnology

Computational Biology and Bioinformatics

• Machine Learning in Biomedical Data Analysis
• Network Biology: Understanding Biological Systems
• Structural Bioinformatics: Predicting Protein Structures
• Data Mining in Genomics and Proteomics
• Systems Biology Approaches in Biotechnology
• Comparative Genomics: Evolutionary Insights
• Bioinformatics Tools for Drug Discovery
• Cloud Computing in Biomedical Research
• Artificial Intelligence in Diagnostics and Treatment
• Computational Approaches to Vaccine Design

Health and Medicine

• Vaccines and Immunotherapy: Advancements in Disease Prevention
• CRISPR-Based Therapies for Genetic Disorders
• Infectious Disease Diagnostics Using Biotechnology
• Telemedicine and Biotechnology Integration
• Biotechnology in Rare Disease Research
• Gut Microbiome and Human Health
• Precision Nutrition: Personalized Diets Using Biotechnology
• Biotechnology Approaches to Combat Antibiotic Resistance
• Point-of-Care Diagnostics for Global Health
• Biotechnology in Aging Research and Longevity

Agricultural Biotechnology

• CRISPR and Gene Editing in Crop Improvement
• Precision Agriculture: Integrating Technology for Crop Management
• Biotechnology Solutions for Food Security
• RNA Interference in Pest Control
• Vertical Farming and Biotechnology
• Plant-Microbe Interactions for Sustainable Agriculture
• Biofortification: Enhancing Nutritional Content in Crops
• Smart Farming Technologies and Biotechnology
• Precision Livestock Farming Using Biotechnological Tools
• Drought-Tolerant Crops: Biotechnological Approaches

Biotechnology and Education

• Integrating Biotechnology into STEM Education
• Virtual Labs in Biotechnology Teaching
• Biotechnology Outreach Programs for Schools
• Online Courses in Biotechnology: Accessibility and Quality
• Hands-on Biotechnology Experiments for Students
• Bioethics Education in Biotechnology Programs
• Role of Internships in Biotechnology Education
• Collaborative Learning in Biotechnology Classrooms
• Biotechnology Education for Non-Science Majors
• Addressing Gender Disparities in Biotechnology Education

Funding and Policy

• Government Funding Initiatives for Biotechnology Research
• Private Sector Investment in Biotechnology Ventures
• Impact of Intellectual Property Policies on Biotechnology
• Ethical Guidelines for Biotechnological Research
• Public-Private Partnerships in Biotechnology
• Regulatory Frameworks for Gene Editing Technologies
• Biotechnology and Global Health Policy
• Biotechnology Diplomacy: International Collaboration
• Funding Challenges in Biotechnology Startups
• Role of Nonprofit Organizations in Biotechnological Research

Biotechnology and the Environment

• Biotechnology for Air Pollution Control
• Microbial Sensors for Environmental Monitoring
• Remote Sensing in Environmental Biotechnology
• Climate Change Mitigation Using Biotechnology
• Circular Economy and Biotechnological Innovations
• Marine Biotechnology for Ocean Conservation
• Bio-inspired Design for Environmental Solutions
• Ecological Restoration Using Biotechnological Approaches
• Impact of Biotechnology on Biodiversity
• Biotechnology and Sustainable Urban Development

Biosecurity and Biosafety

• Biosecurity Measures in Biotechnology Laboratories
• Dual-Use Research and Ethical Considerations
• Global Collaboration for Biosafety in Biotechnology
• Security Risks in Gene Editing Technologies
• Surveillance Technologies in Biotechnological Research
• Biosecurity Education for Biotechnology Professionals
• Risk Assessment in Biotechnology Research
• Bioethics in Biodefense Research
• Biotechnology and National Security
• Public Awareness and Biosecurity in Biotechnology

Industry Applications

• Biotechnology in the Pharmaceutical Industry
• Bioprocessing Innovations for Drug Production
• Industrial Enzymes and Their Applications
• Biotechnology in Food and Beverage Production
• Applications of Synthetic Biology in Industry
• Biotechnology in Textile Manufacturing
• Cosmetic and Personal Care Biotechnology
• Biotechnological Approaches in Renewable Energy
• Advanced Materials Production Using Biotechnology
• Biotechnology in the Automotive Industry

Miscellaneous Topics

• DNA Barcoding in Species Identification
• Bioart: The Intersection of Biology and Art
• Biotechnology in Forensic Science
• Using Biotechnology to Preserve Cultural Heritage
• Biohacking: DIY Biology and Citizen Science
• Microbiome Engineering for Human Health
• Environmental DNA (eDNA) for Biodiversity Monitoring
• Biotechnology and Astrobiology: Searching for Life Beyond Earth
• Biotechnology and Sports Science
• Biotechnology and the Future of Space Exploration

Challenges and Ethical Considerations in Biotechnology Research

As biotechnology continues to advance, it brings forth a set of challenges and ethical considerations. Biosecurity concerns, especially in the context of gene editing technologies, raise questions about the responsible use of powerful tools like CRISPR. 

Ethical implications of genetic manipulation, such as the creation of designer babies, demand careful consideration and international collaboration to establish guidelines and regulations. 

Moreover, the environmental and social impact of biotechnological interventions must be thoroughly assessed to ensure responsible and sustainable practices.

Funding and Resources for Biotechnology Research

The pursuit of biotechnology research topics requires substantial funding and resources. Government grants and funding agencies play a pivotal role in supporting research initiatives. 

Simultaneously, the private sector, including biotechnology companies and venture capitalists, invest in promising projects. Collaboration and partnerships between academia, industry, and nonprofit organizations further amplify the impact of biotechnological research.

Future Prospects of Biotechnology Research

As we look to the future, the integration of biotechnology with other scientific disciplines holds immense potential. Collaborations with fields like artificial intelligence, materials science, and robotics may lead to unprecedented breakthroughs. 

The development of innovative technologies and their application to global health and sustainability challenges will likely shape the future of biotechnology.

In conclusion, biotechnology research is a dynamic and transformative force with the potential to revolutionize multiple facets of our lives. The exploration of diverse biotechnology research topics, from genetic engineering to emerging trends like synthetic biology and nanobiotechnology, highlights the breadth of possibilities within this field. 

However, researchers must navigate challenges and ethical considerations to ensure that biotechnological advancements are used responsibly for the betterment of society. 

With continued funding, collaboration, and a commitment to ethical practices, the future of biotechnology research holds exciting promise, propelling us towards a more sustainable and technologically advanced world.

Related Posts

Step by Step Guide on The Best Way to Finance Car

The Best Way on How to Get Fund For Business to Grow it Efficiently

Research Topics & Ideas

Biotechnology and Genetic Engineering

If you’re just starting out exploring biotechnology-related topics for your dissertation, thesis or research project, you’ve come to the right place. In this post, we’ll help kickstart your research topic ideation process by providing a hearty list of research topics and ideas , including examples from recent studies.

PS – This is just the start…

We know it’s exciting to run through a list of research topics, but please keep in mind that this list is just a starting point . To develop a suitable research topic, you’ll need to identify a clear and convincing research gap , and a viable plan  to fill that gap.

If this sounds foreign to you, check out our free research topic webinar that explores how to find and refine a high-quality research topic, from scratch. Alternatively, if you’d like hands-on help, consider our 1-on-1 coaching service .

Biotechnology Research Topic Ideas

Below you’ll find a list of biotech and genetic engineering-related research topics ideas. These are intentionally broad and generic , so keep in mind that you will need to refine them a little. Nevertheless, they should inspire some ideas for your project.

• Developing CRISPR-Cas9 gene editing techniques for treating inherited blood disorders.
• The use of biotechnology in developing drought-resistant crop varieties.
• The role of genetic engineering in enhancing biofuel production efficiency.
• Investigating the potential of stem cell therapy in regenerative medicine for spinal cord injuries.
• Developing gene therapy approaches for the treatment of rare genetic diseases.
• The application of biotechnology in creating biodegradable plastics from plant materials.
• The use of gene editing to enhance nutritional content in staple crops.
• Investigating the potential of microbiome engineering in treating gastrointestinal diseases.
• The role of genetic engineering in vaccine development, with a focus on mRNA vaccines.
• Biotechnological approaches to combat antibiotic-resistant bacteria.
• Developing genetically engineered organisms for bioremediation of polluted environments.
• The use of gene editing to create hypoallergenic food products.
• Investigating the role of epigenetics in cancer development and therapy.
• The application of biotechnology in developing rapid diagnostic tools for infectious diseases.
• Genetic engineering for the production of synthetic spider silk for industrial use.
• Biotechnological strategies for improving animal health and productivity in agriculture.
• The use of gene editing in creating organ donor animals compatible with human transplantation.
• Developing algae-based bioreactors for carbon capture and biofuel production.
• The role of biotechnology in enhancing the shelf life and quality of fresh produce.
• Investigating the ethics and social implications of human gene editing technologies.
• The use of CRISPR technology in creating models for neurodegenerative diseases.
• Biotechnological approaches for the production of high-value pharmaceutical compounds.
• The application of genetic engineering in developing pest-resistant crops.
• Investigating the potential of gene therapy in treating autoimmune diseases.
• Developing biotechnological methods for producing environmentally friendly dyes.

Biotech & GE Research Topic Ideas (Continued)

• The use of genetic engineering in enhancing the efficiency of photosynthesis in plants.
• Biotechnological innovations in creating sustainable aquaculture practices.
• The role of biotechnology in developing non-invasive prenatal genetic testing methods.
• Genetic engineering for the development of novel enzymes for industrial applications.
• Investigating the potential of xenotransplantation in addressing organ donor shortages.
• The use of biotechnology in creating personalised cancer vaccines.
• Developing gene editing tools for combating invasive species in ecosystems.
• Biotechnological strategies for improving the nutritional quality of plant-based proteins.
• The application of genetic engineering in enhancing the production of renewable energy sources.
• Investigating the role of biotechnology in creating advanced wound care materials.
• The use of CRISPR for targeted gene activation in regenerative medicine.
• Biotechnological approaches to enhancing the sensory qualities of plant-based meat alternatives.
• Genetic engineering for improving the efficiency of water use in agriculture.
• The role of biotechnology in developing treatments for rare metabolic disorders.
• Investigating the use of gene therapy in age-related macular degeneration.
• The application of genetic engineering in developing allergen-free nuts.
• Biotechnological innovations in the production of sustainable and eco-friendly textiles.
• The use of gene editing in studying and treating sleep disorders.
• Developing biotechnological solutions for the management of plastic waste.
• The role of genetic engineering in enhancing the production of essential vitamins in crops.
• Biotechnological approaches to the treatment of chronic pain conditions.
• The use of gene therapy in treating muscular dystrophy.
• Investigating the potential of biotechnology in reversing environmental degradation.
• The application of genetic engineering in improving the shelf life of vaccines.
• Biotechnological strategies for enhancing the efficiency of mineral extraction in mining.

Recent Biotech & GE-Related Studies

While the ideas we’ve presented above are a decent starting point for finding a research topic in biotech, they are fairly generic and non-specific. So, it helps to look at actual studies in the biotech space to see how this all comes together in practice.

Below, we’ve included a selection of recent studies to help refine your thinking. These are actual studies,  so they can provide some useful insight as to what a research topic looks like in practice.

• Genetic modifications associated with sustainability aspects for sustainable developments (Sharma et al., 2022)
• Review On: Impact of Genetic Engineering in Biotic Stresses Resistance Crop Breeding (Abebe & Tafa, 2022)
• Biorisk assessment of genetic engineering — lessons learned from teaching interdisciplinary courses on responsible conduct in the life sciences (Himmel et al., 2022)
• Genetic Engineering Technologies for Improving Crop Yield and Quality (Ye et al., 2022)
• Legal Aspects of Genetically Modified Food Product Safety for Health in Indonesia (Khamdi, 2022)
• Innovative Teaching Practice and Exploration of Genetic Engineering Experiment (Jebur, 2022)
• Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT (Bayer et al., 2022)
• Gene engineering: its positive and negative effects (Makrushina & Klitsenko, 2022)
• Advances of genetic engineering in streptococci and enterococci (Kurushima & Tomita, 2022)
• Genetic Engineering of Immune Evasive Stem Cell-Derived Islets (Sackett et al., 2022)
• Establishment of High-Efficiency Screening System for Gene Deletion in Fusarium venenatum TB01 (Tong et al., 2022)
• Prospects of chloroplast metabolic engineering for developing nutrient-dense food crops (Tanwar et al., 2022)
• Genetic research: legal and ethical aspects (Rustambekov et al., 2023). Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Complexes into Plant Nuclei and Chloroplasts (Thagun et al., 2022)
• The role of genetic breeding in food security: A review (Sam et al., 2022). Biotechnology: use of available carbon sources on the planet to generate alternatives energy (Junior et al., 2022)
• Biotechnology and biodiversity for the sustainable development of our society (Jaime, 2023) Role Of Biotechnology in Agriculture (Shringarpure, 2022)
• Plants That Can be Used as Plant-Based Edible Vaccines; Current Situation and Recent Developments (İsmail, 2022)

As you can see, these research topics are a lot more focused than the generic topic ideas we presented earlier. So, in order for you to develop a high-quality research topic, you’ll need to get specific and laser-focused on a specific context with specific variables of interest.  In the video below, we explore some other important things you’ll need to consider when crafting your research topic.

Get 1-On-1 Help

If you’re still unsure about how to find a quality research topic, check out our Research Topic Kickstarter service, which is the perfect starting point for developing a unique, well-justified research topic.

i want to write a research concept for my scholarship now i don’t know how to write it. my study area of interest is Master of Science in molecular biology. my proposed research topics are

1. use of genetic engineering in developing climate change resilient crops. 2. biotechnology in farming; improving drought resistance, pest and disease control

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

• Print Friendly

Loading metrics

Open Access

The future is bright, the future is biotechnology

* E-mail: [email protected]

Affiliation Public Library of Science, San Francisco, California, United States of America and Cambridge, United Kingdom

• Richard Hodge, 
• on behalf of the PLOS Biology staff editors

Published: April 28, 2023

• https://doi.org/10.1371/journal.pbio.3002135
• Reader Comments

As PLOS Biology celebrates its 20 th anniversary, our April issue focuses on biotechnology with articles covering different aspects of the field, from genome editing to synthetic biology. With them, we emphasize our interest in expanding our presence in biotechnology research.

Citation: Hodge R, on behalf of the PLOS Biology staff editors (2023) The future is bright, the future is biotechnology. PLoS Biol 21(4): e3002135. https://doi.org/10.1371/journal.pbio.3002135

Copyright: © 2023 Hodge, on behalf of the PLOS Biology staff editors. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The authors received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

The PLOS Biology Staff Editors are Ines Alvarez-Garcia, Joanna Clarke, RichardHodge, Paula Jauregui, Nonia Pariente, Roland Roberts, and Lucas Smith.

This article is part of the PLOS Biology 20th Anniversary Collection.

Biotechnology is a revolutionary branch of science at the forefront of research and innovation that has advanced rapidly in recent years. It is a broad discipline, in which organisms or biological processes are exploited to develop new technologies that have the potential to transform the way we live and work, as well as to boost sustainability and industrial productivity. The new tools and products being generated have a wide range of applications across various sectors, including medicine, agriculture, energy, manufacturing and food.

PLOS Biology has traditionally published research reporting significant advances across a wide range of biological disciplines. However, our scope must continue to evolve as biology increasingly becomes more and more applied, generating technologies with potentially game-changing therapeutic and environmental impact. To that end, we recently published a collection of magazine articles focused on ideas for green biotechnologies that could have an important role in a sustainable future [ 1 ], including how to harness microbial photosynthesis to directly generate electricity [ 2 ] and using microbes to develop carbon “sinks” in the mining industry [ 3 ]. Moreover, throughout this anniversary year we are publishing Perspective articles that take stock of the past 20 years of biological research in a specific field and look forward to what is to come in the next 20 years [ 4 ]; in this issue, these Perspectives focus on different aspects of the broad biotechnology field—synthetic biology [ 5 ] and the use of lipid nanoparticles (LNPs) for the delivery of therapeutics [ 6 ].

One fast moving area within biotechnology is gene editing therapy, which involves the alteration of DNA to treat or prevent disease using techniques such as CRISPR-Cas9 and base editors that enable precise genetic modifications to be made. This approach shows great promise for treating a variety of genetic diseases. Excitingly, promising phase I results of the first in vivo genome editing clinical trial to treat several liver-related diseases were reported at the recent Keystone Symposium on Precision Genome Engineering. This issue of PLOS Biology includes an Essay from Porto and Komor that focuses on the clinical applications of base editor technology [ 7 ], which could enable chronic diseases to be treated with a ‘one-and-done’ therapy, and a Perspective from Hamilton and colleagues that outlines the advances in the development of LNPs for the delivery of nucleic acid-based therapeutics [ 6 ]. LNPs are commonly used as vehicles for the delivery of such therapeutics because they have a low immunogenicity and can be manufactured at scale. However, expanding the toolbox of delivery platforms for these novel therapeutics will be critical to realise their full clinical potential.

Synthetic biology is also a rapidly growing area, whereby artificial or existing biological systems are designed to produce products or enhance cellular function. By using CRISPR to edit genes involved in metabolic pathways, researchers can create organisms that produce valuable compounds such as biofuels, drugs, and industrial chemicals. In their Perspective, Kitano and colleagues take stock of the technological advances that have propelled the “design-build-test-learn” cycle methodology forward in synthetic biology, as well as focusing on how machine-learning approaches can remove the bottlenecks in these pipelines [ 5 ].

While the potential of these technologies is vast, there are also concerns about their safety and ethical implications. Gene editing, in particular, raises ethical concerns, as it could be used to create so-called “designer babies” with specific traits or to enhance physical or mental capabilities. There are also concerns about the unintended consequences of gene editing, such as off-target effects that could cause unintended harm. These technologies can be improved by better understanding the interplay between editing tools and DNA repair pathways, and it will be essential for scientists and policymakers to be cautious and work together to establish guidelines and regulations for their use, as outlined at the recent International Summit on Human Genome Editing .

Basic research has also benefitted from biotechnological developments. For instance, methodological developments in super-resolution microscopy offer researchers the ability to image cells at exquisite detail and answer previously inaccessible research questions. Sequencing technologies such as Nanopore sequencers are revolutionising the ability to sequence long DNA/RNA reads in real time and in the field. Great strides have also been made in the development of analysis software for structural biology purposes, such as sub-tomogram averaging for cryo-EM [ 8 ]. The rate of scientific discovery is now at an unprecedented level in this age of big data as a result of these huge technological leaps.

The past few years has also seen the launch of AI tools such as ChatGPT. While these tools are increasingly being used to help write students homework or to improve the text of scientific papers, generative AI tools hold the potential to transform research and development in the biotechnology industry. The recently developed language model ProGen can generate and then predict function in protein sequences [ 9 ], and these models can also be used to find therapeutically relevant compounds for drug discovery. Protein structure prediction programs, such as AlphaFold [ 10 ] and RosettaFold, have revolutionized structural biology and can be used for a myriad of purposes. We have recently published several papers that have utilized AlphaFold models to develop methods that determine the structural context of post-translational modifications [ 11 ] and predict autophagy-related motifs in proteins [ 12 ].

The future of biotechnology is clearly very promising and we look forward to being part of the dissemination of these important new developments. Open access science sits at the core of our mission and the publication of these novel technologies in PLOS Biology can help their widespread adoption and ensure global access. As we look forward during this year of celebration, we are excited that biotechnology research will continue to grow and become a central part of the journal. The future is bright and the future is very much biotechnology.

• View Article
• PubMed/NCBI
• Google Scholar

Top 50 Research Topics in Biotechnology

Table of Contents

Biotechnology

Research in biotechnology can helps in bringing massive changes in humankind and lead to a better life. In the last few years, there have been so many leaps, and paces of innovations as scientists worldwide worked to develop and produce novel mRNA vaccinations and brought some significant developments in biotechnology. During this period, they also faced many challenges. Disturbances in the supply chain and the pandemic significantly impacted biotech labs and researchers, forcing lab managers to become ingenious in buying lab supplies, planning experiments, and using technology for maintaining research schedules.

The Biotech Research Technique is changing

How research is being done is changing, as also how scientists are conducting it. Affected by both B2C eCommerce and growing independence in remote and cloud-dependent working, most of the biotechnology labs are going through some digital transformations. This implies more software, automation, and AI in the biotech lab, along with some latest digital procurement plans and integrated systems for various lab operations.

Look at some of the top trends in biotech research and recent Biotechnology Topics that are bringing massive changes in this vast world of science, resulting in some innovation in life sciences and biotechnology ideas .

We share different job or exam notices on Labmonk Notice Board . You can search “ Labmonk Notice Board ” on google search to check out latest jobs of your field.

Leave a Comment Cancel reply

• Interesting
• Scholarships
• UGC-CARE Journals

Top 50 Emerging Research Topics in Biotechnology

Trending Research Topics in Biotechnology

Biotechnology is a dynamic field that continuously shapes our world, enabling innovation, breakthroughs, and solutions to various challenges. As we move into the future, numerous emerging research areas promise to revolutionize healthcare, agriculture, environmental sustainability, and more. The top 50 emerging research topics in biotechnology are presented in this article.

1. Gene Editing and Genomic Engineering

a. CRISPR and Gene Editing

Precision Medicine : Developing targeted therapies for various diseases using CRISPR/Cas9 and other gene-editing tools.

Ethical Implications : Exploring and addressing ethical concerns surrounding CRISPR use in human embryos and germline editing.

Agricultural Advancements : Enhancing crop resistance and nutritional content through gene editing of improved farm outcomes.

Gene Drive Technology : Investigating the potential of gene drive technology to control vector-borne diseases like malaria and dengue fever.

Regulatory Frameworks : Establishing global regulations for responsible gene editing applications in different fields.

b. Synthetic Biology

Bioengineering Microbes : Creating engineered microorganisms for sustainable production of fuels, pharmaceuticals, and materials.

Designer Organisms : Designing novel organisms with specific functionalities for environmental remediation or industrial processes.

Cell-Free Systems : Developing cell-free systems for various applications, including drug production and biosensors.

Biosecurity Measures : Addressing concerns regarding the potential misuse of synthetic biology for bioterrorism.

Standardization and Automation : Standardizing synthetic biology methodologies and automating processes to streamline production.

2. Personalized Medicine and Pharmacogenomics

a. Precision Medicine

Individualized Treatment : Tailoring medical treatment based on a person’s genetic makeup and environmental factors.

Cancer Therapy : Advancing targeted cancer therapies based on the genetic profile of tumors and patients.

Data Analytics : Implementing big data and AI for comprehensive analysis of genomic and clinical data to improve treatment outcomes.

Clinical Implementation : Integrating genetic testing into routine clinical practice for personalized healthcare.

Public Health and Policy : Addressing the challenges of integrating personalized medicine into public health policies and practices.

b. Pharmacogenomics

Drug Development : Optimizing drug development based on individual genetic variations to improve efficacy and reduce side effects.

Adverse Drug Reactions : Understanding genetic predispositions to adverse drug reactions and minimizing risks.

Dosing Optimization : Tailoring drug dosage based on an individual’s genetic profile for better treatment outcomes.

Economic Implications : Assessing the economic impact of pharmacogenomics on healthcare systems.

Education and Training : Educating healthcare professionals on integrating pharmacogenomic data into clinical practice.

3. Nanobiotechnology and Nanomedicine

a. Nanoparticles in Medicine

Drug Delivery Systems : Developing targeted drug delivery systems using nanoparticles for enhanced efficacy and reduced side effects.

Theranostics : Integrating diagnostics and therapeutics through nanomaterials for personalized medicine.

Imaging Techniques : Advancing imaging technologies using nanoparticles for better resolution and early disease detection.

Biocompatibility and Safety : Ensuring the safety and biocompatibility of nanoparticles used in medicine.

Regulatory Frameworks : Establishing regulations for the use of nanomaterials in medical applications.

b. Nanosensors and Diagnostics

Point-of-Care Diagnostics : Developing portable and rapid diagnostic tools for various diseases using nanotechnology.

Biosensors : Creating highly sensitive biosensors for detecting biomarkers and pathogens in healthcare and environmental monitoring.

Wearable Health Monitors : Integrating nanosensors into wearable devices for continuous health monitoring.

Challenges and Limitations : Addressing challenges in scalability, reproducibility, and cost-effectiveness of nanosensor technologies.

Future Applications : Exploring potential applications of nanosensors beyond healthcare, such as environmental monitoring and food safety.

4. Immunotherapy and Vaccine Development

a. Cancer Immunotherapy

Immune Checkpoint Inhibitors : Enhancing the efficacy of immune checkpoint inhibitors and understanding resistance mechanisms.

CAR-T Cell Therapy : Improving CAR-T cell therapy for a wider range of cancers and reducing associated side effects.

Combination Therapies : Investigating combination therapies for better outcomes in cancer treatment.

Biomarkers and Predictive Models : Identifying predictive biomarkers for immunotherapy response.

Long-Term Effects : Studying the long-term effects and immune-related adverse events of immunotherapies.

b. Vaccine Technology

mRNA Vaccines : Advancing mRNA vaccine technology for various infectious diseases and cancers.

Universal Vaccines : Developing universal vaccines targeting multiple strains of viruses and bacteria.

Vaccine Delivery Systems : Innovating vaccine delivery methods for improved stability and efficacy.

Vaccine Hesitancy : Addressing vaccine hesitancy through education, communication, and community engagement.

Pandemic Preparedness : Developing strategies for rapid vaccine development and deployment during global health crises.

5. Environmental Biotechnology and Sustainability

a. Bioremediation and Bioenergy

Biodegradation Techniques : Using biotechnology to enhance the degradation of pollutants and contaminants in the environment.

Biofuels : Developing sustainable biofuel production methods from renewable resources.

Microbial Fuel Cells : Harnessing microbial fuel cells for energy generation from organic waste.

Circular Economy : Integrating biotechnological solutions for a circular economy and waste management.

Ecosystem Restoration : Using biotechnology for the restoration of ecosystems affected by pollution and climate change.

b. Agricultural Biotechnology

Genetically Modified Crops : Advancing genetically modified crops for improved yields, pest resistance, and nutritional content.

Precision Agriculture : Implementing biotechnological tools for precise and sustainable farming practices.

Climate-Resilient Crops : Developing crops resilient to climate change-induced stresses.

Micro-biome Applications : Leveraging the plant micro-biome for enhanced crop health and productivity.

Consumer Acceptance and Regulation : Addressing consumer concerns and regulatory challenges related to genetically modified crops.

The field of biotechnology is a beacon of hope for addressing the challenges of our time, offering promising solutions for healthcare, sustainability, and more. As researchers explore these emerging topics, the potential for ground-breaking discoveries and transformative applications is immense.

I hope this article will help you to find the top research topics in biotechnology that promise to revolutionize healthcare, agriculture, environmental sustainability, and more.

• Drug delivery
• Environmental Engineering
• Gene editing
• Genomic Engineering
• Molecular Biology
• Nanoparticles
• Pharmacogenomics
• Research Ideas
• Synthetic biology

Abstract Template for Research Paper

Top 50 research institutions in india: nirf rankings 2024, how to create graphical abstract, most popular, 10 types of plagiarism – every academic writer should know – updated, the harsh reality: why revoked graduate degrees aren’t easily reclaimed, top 35 scopus indexed journals in english literature, list of research topics in environmental engineering, indo-russian joint research call for proposals 2024, newly accepted scopus indexed journals june 2024, top 10 scopus indexed agronomy and crop science journals, best for you, 24 best online plagiarism checker free – 2024, what is phd, popular posts, popular category.

• POSTDOC 317
• Interesting 257
• Journals 235
• Fellowship 133
• Research Methodology 102
• All Scopus Indexed Journals 93

Mail Subscription

iLovePhD is a research education website to know updated research-related information. It helps researchers to find top journals for publishing research articles and get an easy manual for research tools. The main aim of this website is to help Ph.D. scholars who are working in various domains to get more valuable ideas to carry out their research. Learn the current groundbreaking research activities around the world, love the process of getting a Ph.D.

Contact us: [email protected]

Google News

Copyright © 2024 iLovePhD. All rights reserved

• Artificial intelligence

• Search by keyword
• Search by citation

Page 1 of 36

Comparison of lipidome profiles in serum from lactating dairy cows supplemented with Acremonium terrestris culture based on UPLC-QTRAP-MS/MS

This study evaluated the effects of supplementing the diet of lactating cows with Acremonium terrestris culture (ATC) on milk production, serum antioxidant capacity, inflammatory indices, and serum lipid metabolo...

• View Full Text

Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a malignant tumour. Although some standard therapies have been established to improve the cure rate, they remain ineffective for specific individuals. Therefore, it is ...

Antimicrobial and cytotoxic activities of flavonoid and phenolics extracted from Sepia pharaonis ink (Mollusca: Cephalopoda)

Several studies have been reported previously on the bioactivities of different extracts of marine molluscs. Therefore, we decided to evaluate the cytotoxic and antimicrobial activities of S. pharaonis ink as a h...

Biocompatibility and potential anticancer activity of gadolinium oxide (Gd 2 O 3 ) nanoparticles against nasal squamous cell carcinoma

Chemotherapy as a cornerstone of cancer treatment is slowly being edged aside owing to its severe side effects and systemic toxicity. In this case, nanomedicine has emerged as an effective tool to address thes...

In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: an insight into nano delivery system

Colorectal cancer is a common disease worldwide with non-specific symptoms such as blood in the stool, bowel movements, weight loss and fatigue. Chemotherapy drugs can cause side effects such as nausea, vomiti...

Ferula latisecta gels for synthesis of zinc/silver binary nanoparticles: antibacterial effects against gram-negative and gram-positive bacteria and physicochemical characteristics

This study explores the potential antibacterial applications of zinc oxide nanoparticles (ZnO NPs) enhanced with silver (Ag) using plant gel (ZnO-AgO NPs). The problem addressed is the increasing prevalence of...

Validation of a rapid collagenase activity detection technique based on fluorescent quenched gelatin with synovial fluid samples

Measuring collagenase activity is crucial in the field of joint health and disease management. Collagenases, enzymes responsible for collagen degradation, play a vital role in maintaining the balance between c...

Characterization of a thermostable protease from Bacillus subtilis BSP strain

This study used conservative one variable-at-a-time study and statistical surface response methods to increase the yields of an extracellular thermostable protease secreted by a newly identified thermophilic Baci...

Recombinant human enamelin produced in Escherichia coli promotes mineralization in vitro

Enamelin is an enamel matrix protein that plays an essential role in the formation of enamel, the most mineralized tissue in the human body. Previous studies using animal models and proteins from natural sourc...

Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections

The threat of methicillin-resistant Staphylococcus aureus (MRSA) is increasing worldwide, making it significantly necessary to discover a novel way of dealing with related infections. The quick spread of MRSA iso...

Optimisation of indole acetic acid production by Neopestalotiopsis aotearoa endophyte isolated from Thymus vulgaris and its impact on seed germination of Ocimum basilicum

Microbial growth during plant tissue culture is a common problem that causes significant losses in the plant micro-propagation system. Most of these endophytic microbes have the ability to propagate through ho...

Design of a novel multi-epitope vaccine against Marburg virus using immunoinformatics studies

Marburg virus (MARV) is a highly contagious and virulent agent belonging to Filoviridae family. MARV causes severe hemorrhagic fever in humans and non-human primates. Owing to its highly virulent nature, preventi...

Increased stable integration efficiency in CHO cells through enhanced nuclear localization of Bxb1 serine integrase

Mammalian display is an appealing technology for therapeutic antibody development. Despite the advantages of mammalian display, such as full-length IgG display with mammalian glycosylation and its inherent abi...

Screening of Candida spp. in wastewater in Brazil during COVID-19 pandemic: workflow for monitoring fungal pathogens

Fungal diseases are often linked to poverty, which is associated with poor hygiene and sanitation conditions that have been severely worsened by the COVID-19 pandemic. Moreover, COVID-19 patients are treated w...

Transgenic Arabidopsis thaliana plants expressing bacterial γ-hexachlorocyclohexane dehydrochlorinase LinA

γ-Hexachlorocyclohexane (γ-HCH), an organochlorine insecticide of anthropogenic origin, is a persistent organic pollutant (POP) that causes environmental pollution concerns worldwide. Although many γ-HCH-degra...

Molecular and agro-morphological characterization of new barley genotypes in arid environments

Genetic diversity, population structure, agro-morphological traits, and molecular characteristics, are crucial for either preserving genetic resources or developing new cultivars. Due to climate change, water ...

Microvesicles-delivering Smad7 have advantages over microvesicles in suppressing fibroblast differentiation in a model of Peyronie’s disease

This study compared the differences of microvesicles (MVs) and microvesicles-delivering Smad7 (Smad7-MVs) on macrophage M1 polarization and fibroblast differentiation in a model of Peyronie’s disease (PD).

Improvement and prediction of the extraction parameters of lupeol and stigmasterol metabolites of Melia azedarach with response surface methodology

Melia azedarach is known as a medicinal plant that has wide biological activities such as analgesic, antibacterial, and antifungal effects and is used to treat a wide range of diseases such as diarrhea, malaria, ...

Dual release of daptomycin and BMP-2 from a composite of β-TCP ceramic and ADA gelatin

Antibiotic-containing carrier systems are one option that offers the advantage of releasing active ingredients over a longer period of time. In vitro sustained drug release from a carrier system consisting of ...

Minimizing IP issues associated with gene constructs encoding the Bt toxin - a case study

As part of a publicly funded initiative to develop genetically engineered Brassicas (cabbage, cauliflower, and canola) expressing Bacillus thuringiensis Crystal ( Cry )-encoded insecticidal (Bt) toxin for Indian an...

Activating the healing process: three-dimensional culture of stem cells in Matrigel for tissue repair

To establish a strategy for stem cell-related tissue regeneration therapy, human gingival mesenchymal stem cells (hGMSCs) were loaded with three-dimensional (3D) bioengineered Matrigel matrix scaffolds in high...

Co-overexpression of chitinase and β-1,3-glucanase significantly enhanced the resistance of Iranian wheat cultivars to Fusarium

Fusarium head blight (FHB) is a devastating fungal disease affecting different cereals, particularly wheat, and poses a serious threat to global wheat production. Chitinases and β-glucanases are two important ...

A new mRNA structure prediction based approach to identifying improved signal peptides for bone morphogenetic protein 2

Signal peptide (SP) engineering has proven able to improve production of many proteins yet is a laborious process that still relies on trial and error. mRNA structure around the translational start site is imp...

Correction: Transcriptomic and targeted metabolomic analyses provide insights into the flavonoids biosynthesis in the flowers of Lonicera macranthoides

The original article was published in BMC Biotechnology 2024 24 :19

A model approach to show that monocytes can enter microporous β-TCP ceramics

β-TCP ceramics are versatile bone substitute materials and show many interactions with cells of the monocyte-macrophage-lineage. The possibility of monocytes entering microporous β-TCP ceramics has however not...

Nutritional composition, lipid profile and stability, antioxidant activities and sensory evaluation of pasta enriched by linseed flour and linseed oil

Pasta assortments fortified with high quality foods are a modern nutritional trends. This study, explored the effects of fortification with linseed flour (LF) and linseed oil (LO) on durum wheat pasta characte...

In vitro assessment of the effect of magnetic fields on efficacy of biosynthesized selenium nanoparticles by Alborzia kermanshahica

Cyanobacteria represent a rich resource of a wide array of unique bioactive compounds that are proving to be potent sources of anticancer drugs. Selenium nanoparticles (SeNPs) have shown an increasing potentia...

ECM-mimetic, NSAIDs loaded thermo-responsive, immunomodulatory hydrogel for rheumatoid arthritis treatment

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, and it leads to irreversible inflammation in intra-articular joints. Current treatment approaches for RA include non-steroidal anti-infla...

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

Venous thromboembolism (VTE), is a noteworthy complication in individuals with gastric cancer, but the current diagnosis and treatment methods lack accuracy. In this study, we developed a t-PAIC chemiluminesce...

High-performance internal circulation anaerobic granular sludge reactor for cattle slaughterhouse wastewater treatment and simultaneous biogas production

This research investigates the efficacy of a high-performance pilot-scale Internal Circulation Anaerobic Reactor inoculated with Granular Sludge (ICAGSR) for treating cattle slaughterhouse wastewater while con...

Hindering the biofilm of microbial pathogens and cancer cell lines development using silver nanoparticles synthesized by epidermal mucus proteins from Clarias gariepinus

Scientists know very little about the mechanisms underlying fish skin mucus, despite the fact that it is a component of the immune system. Fish skin mucus is an important component of defence against invasive ...

3D printing of Ceffe-infused scaffolds for tailored nipple-like cartilage development

The reconstruction of a stable, nipple-shaped cartilage graft that precisely matches the natural nipple in shape and size on the contralateral side is a clinical challenge. While 3D printing technology can eff...

A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861

Treatment with tumor-targeted toxins attempts to overcome the disadvantages of conventional cancer therapies by directing a drug’s cytotoxic effect specifically towards cancer cells. However, success with targ...

Multiprotein collagen/keratin hydrogel promoted myogenesis and angiogenesis of injured skeletal muscles in a mouse model

Volumetric loss is one of the challenging issues in muscle tissue structure that causes functio laesa . Tissue engineering of muscle tissue using suitable hydrogels is an alternative to restoring the physiological...

Analysis of the impact of pluronic acid on the thermal stability and infectivity of AAV6.2FF

The advancement of AAV vectors into clinical testing has accelerated rapidly over the past two decades. While many of the AAV vectors being utilized in clinical trials are derived from natural serotypes, engin...

Rice yellow mottle virus is a suitable amplicon vector for an efficient production of an anti-leishmianiasis vaccine in Nicotiana benthamiana leaves

Since the 2000’s, plants have been used as bioreactors for the transient production of molecules of interest such as vaccines. To improve protein yield, “amplicon” vectors based on plant viruses are used. Thes...

Extraction and analysis of high-quality chloroplast DNA with reduced nuclear DNA for medicinal plants

Obtaining high-quality chloroplast genome sequences requires chloroplast DNA (cpDNA) samples that meet the sequencing requirements. The quality of extracted cpDNA directly impacts the efficiency and accuracy o...

Transcriptomic and targeted metabolomic analyses provide insights into the flavonoids biosynthesis in the flowers of Lonicera macranthoides

Flavonoids are one of the bioactive ingredients of Lonicera macranthoides ( L. macranthoides ), however, their biosynthesis in the flower is still unclear. In this study, combined transcriptomic and targeted metabo...

The Correction to this article has been published in BMC Biotechnology 2024 24 :33

Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity

Nanotechnology-based drug delivery systems have received much attention over the past decade. In the present study, we synthesized Methyl Urolithin A-loaded solid lipid nanoparticles decorated with the folic a...

Neq2X7: a multi-purpose and open-source fusion DNA polymerase for advanced DNA engineering and diagnostics PCR

Thermostable DNA polymerases, such as Taq isolated from the thermophilic bacterium Thermus aquaticus , enable one-pot exponential DNA amplification known as polymerase chain reaction (PCR). However, properties oth...

A solution for highly efficient electroporation of primary cytotoxic T lymphocytes

Cytotoxic T lymphocytes (CTLs) are central players in the adaptive immune response. Their functional characterization and clinical research depend on efficient and reliable transfection. Although various metho...

Adsorption of Hg 2+ /Cr 6+ by metal-binding proteins heterologously expressed in Escherichia coli

Removal of heavy metals from water and soil is a pressing challenge in environmental engineering, and biosorption by microorganisms is considered as one of the most cost-effective methods. In this study, the m...

Derivation of a novel antimicrobial peptide from the Red Sea Brine Pools modified to enhance its anticancer activity against U2OS cells

Cancer associated drug resistance is a major cause for cancer aggravation, particularly as conventional therapies have presented limited efficiency, low specificity, resulting in long term deleterious side eff...

Polyphyllin B inhibited STAT3/NCOA4 pathway and restored gut microbiota to ameliorate lung tissue injury in cigarette smoke-induced mice

Smoking was a major risk factor for chronic obstructive pulmonary disease (COPD). This study plan to explore the mechanism of Polyphyllin B in lung injury induced by cigarette smoke (CSE) in COPD.

Quantifying carboxymethyl lysine and carboxyethyl lysine in human plasma: clinical insights into aging research using liquid chromatography-tandem mass spectrometry

The objective of this study was to establish a methodology for determining carboxymethyl lysine (CML) and carboxyethyl lysine (CEL) concentrations in human plasma using liquid chromatography-tandem mass spectr...

Iron/Copper/Phosphate nanocomposite as antimicrobial, antisnail, and wheat growth-promoting agent

One of the current challenges is to secure wheat crop production to meet the increasing global food demand and to face the increase in its purchasing power. Therefore, the current study aimed to exploit a new ...

Staphopain mediated virulence and antibiotic resistance alteration in co-infection of Staphylococcus aureus and Pseudomonas aeruginosa : an animal model

Polymicrobial communities lead to worsen the wound infections, due to mixed biofilms, increased antibiotic resistance, and altered virulence production. Promising approaches, including enzymes, may overcome th...

Strain-specific features of Pleurotus ostreatus growth in vitro and some of its biological activities

The production of Pleurotus ostreatus mycelium as a promising object for use in food and other industries is hampered by a lack of information about the strain-specificity of this fungus mycelium growth and its a...

Antibacterial, antibiofilm, and anticancer activity of silver-nanoparticles synthesized from the cell-filtrate of Streptomyces enissocaesilis

Silver nanoparticles (Ag-NPs) have a unique mode of action as antibacterial agents in addition to their anticancer and antioxidant properties. In this study, microbial nanotechnology is employed to synthesize ...

Deep orange gene editing triggers temperature-sensitive lethal phenotypes in Ceratitis capitata

The Mediterranean fruit fly, Ceratitis capitata , is a significant agricultural pest managed through area-wide integrated pest management (AW-IPM) including a sterile insect technique (SIT) component. Male-only re...

Important information

Editorial board

For authors

For editorial board members

For reviewers

• Manuscript editing services
• Follow us on Twitter

Annual Journal Metrics

Citation Impact 2023 Journal Impact Factor: 3.5 5-year Journal Impact Factor: 3.2 Source Normalized Impact per Paper (SNIP): 0.933 SCImago Journal Rank (SJR): 0.724 Speed 2023 Submission to first editorial decision (median days): 11 Submission to acceptance (median days): 155 Usage 2023 Downloads: 1,134,875 Altmetric mentions: 518

• More about our metrics

BMC Biotechnology

ISSN: 1472-6750

• General enquiries: [email protected]

• Google Meet
• Mobile Dialer

Resent Search

Academic Counselling Sessions

Academic Counselling and Sample Service

Professional Proofreading Services

Technical Assistance

Counseling Sample & Proofreading

Research Proposal Topics In Biotechnology

Biotechnology is a fascinating subject that blends biology and technology and provides a huge chance to develop new ideas. However, before pursuing a career in this field, a person needs to complete a number of studies and have a thorough knowledge of the matter. When we begin our career must we conduct study to discover some innovative innovations that could benefit people around the world. Biotechnology is one of a variety of sciences of life, including pharmacy. Students who are pursuing graduation, post-graduation or PhD must complete the research work and compose their thesis to earn the satisfaction in their education. When choosing a subject for biotechnology-related research it is important to choose one that is likely to inspire us. Based on our passion and personal preferences, the subject to study may differ.

What is Biotechnology?

In its most basic sense, biotechnology is the science of biology that enables technology Biotechnology harnesses the power of the biomolecular and cellular processes to create products and technologies that enhance our lives and the wellbeing of the planet. Biotechnology has been utilizing microorganisms' biological processes for over six thousand years to create useful food items like cheese and bread as well as to keep dairy products in good condition.

Modern biotechnology has created breakthrough products and technology to treat rare and debilitating illnesses help reduce our footprint on the environment and feed hungry people, consume less energy and use less and provide safer, more clean and productive industrial production processes.

Introduction

Biotechnology is credited with groundbreaking advancements in technological development and development of products to create sustainable and cleaner world. This is in large part due to biotechnology that we've made progress toward the creation of more efficient industrial manufacturing bases. Additionally, it assists in the creation of greener energy, feeding more hungry people and not leaving a large environmental footprint, and helping humanity fight rare and fatal diseases.

Our writing services for assignments within the field of biotechnology covers all kinds of subjects that are designed to test and validate the skills of students prior to awarding their certificates. We assist students to successfully complete their course in all kinds of biotechnology-related courses. This includes biological sciences for medical use (red) and eco-biotechnology (green) marine biotechnology (blue) and industrial biotechnology (white).

What do we hope to gain from all these Initiatives?

Our primary goal in preparing this list of the top 100 biotechnology assignment subjects is to aid students in deciding on effective time management techniques. We've witnessed a large amount of cases where when looking for online help with assignments with the topic, examining sources of information, and citing the correct order of reference students find themselves stuck at various points. In the majority of cases, students have difficulty even to get through their dilemma of choosing a topic. This is why we contribute in our effort to help make the process easier for students in biotech quickly and efficiently. Our students are able to save time and energy in order to help them make use of the time they are given to write the assignment with the most appropriate topics.

Let's look at some of the newest areas of biotechnology research and the related areas.

• Renewable Energy Technology Management Promoting Village
• Molasses is a molasses-based ingredient that can be used to produce and the treatment of its effluent
• Different ways to evapotranspirate
• Scattering Parameters of Circulator Bio-Technology
• Renewable Energy Technology Management Promoting Village.

Structural Biology of Infectious Diseases

A variety of studies are being conducted into the techniques used by pathogens in order to infect humans and other species and for designing strategies for countering the disease. The main areas that are available to study by biotech researchers include:

• inlA from Listeria monocytogenes when combined with E-cadherin from humans.
• InlC in Listeria monocytogenes that are multipart with human Tuba.
• Phospholipase PatA of Legionella pnemophila.
• The inactivation process of mammalian TLR2 by inhibiting antibody.
• There are many proteins that come originate from Mycobacterium tuberculosis.

Plant Biotechnology

Another significant area for research in biotechnology for plants is to study the genetic causes of the plant's responses to scarcity and salinity, which have a significant impact on yields of the crop and food.

• Recognition and classification of genes that influence the responses of plants to drought and salinity.
• A component of small-signing molecules in plants' responses to salinity and drought.
• Genetic enhancement of plant sensitivity salinity and drought.

Pharmacogenetics

It's also a significant area for conducting research in biotechnology. One of the most important reasons for doing so could be the identification of various genetic factors that cause differences in drug effectiveness and susceptibility for adverse reactions. Some of the subjects which can be studied are,

• Pharmacogenomics of Drug Transporters
• Pharmacogenomics of Metformin's response to type II mellitus
• The pharmacogenomics behind anti-hypertensive medicines
• The Pharmacogenomics of anti-cancer drugs

Forensic DNA

A further area of research in biotechnology research is the study of the genetic diversity of humans for its applications in criminal justice. Some of the topics that could be studied include,

• Y-chromosome Forensic Kit, Development of commercial prototype.
• Genetic testing of Indels in African populations.
• The Y-chromosome genotyping process is used for African populations.
• Study of paternal and maternal ancestry of mixed communities in South Africa.
• The study of the local diversity in genetics using highly mutating Y-STRs and Indels.
• South African Innocence Project: The study of DNA extracted from historical crime scene.
• Nanotechnology is a new technology that can be applied to DNA genotyping.
• Nanotechnology methods to isolate DNA.

Food Biotechnology

It is possible to conduct research in order to create innovative methods and processes in the fields of food processing and water. The most fascinating topics include:

• A molecular-based technology that allows for the rapid identification and detection of foodborne pathogens in intricate food chains.
• The effects of conventional and modern processing techniques on the bacteria that are associated with Aspalathus lineriasis.
• DNA-based identification of species of animals that are present in meat products that are sold raw.
• The phage assay and PCR are used to detect and limit the spread of foodborne pathogens.
• Retention and elimination of pathogenic, heat-resistant and other microorganisms that are treated by UV-C.
• Analysis of an F1 generation of the cross Bon Rouge x Packham's Triumph by Simple Sequence Repeat (SSR/microsatellite).
• The identification of heavy metal tolerant and sensitive genotypes
• Identification of genes that are involved in tolerance to heavy metals
• The isolation of novel growth-promoting bacteria that can help crops cope with heavy metal stress . Identification of proteins that signal lipids to increase the tolerance of plants to stress from heavy metals

This topic includes high-resolution protein expression profiling for the investigation of proteome profiles. The following are a few of the most fascinating topics:

• The identification and profile of stress-responsive proteins that respond to abiotic stress in Arabidopsis Thalian and Sorghum bicolor.
• Analyzing sugar biosynthesis-related proteins in Sorghum bicolor, and study of their roles in drought stress tolerance
• Evaluation of the viability and long-term sustainability of Sweet Sorghum for bioethanol (and other by-products) production in South Africa
• In the direction of developing an environmentally sustainable, low-tech hypoallergenic latex Agroprocessing System designed specifically especially for South African small-holder farmers.

Bioinformatics

This is an additional aspect of biotechnology research. The current trend is to discover new methods to combat cancer. Bioinformatics may help identify proteins and genes as well as their role in the fight against cancer. Check out some of the areas that are suitable to study.

• Prediction of anticancer peptides with HIMMER and the the support vector machine.
• The identification and verification of innovative therapeutic antimicrobial peptides for Human Immunodeficiency Virus In the lab and molecular method.
• The identification of biomarkers that are associated with cancer of the ovary using an molecular and in-silico method.
• Biomarkers identified in breast cancer, as possible therapeutic and diagnostic agents with a combination of molecular and in-silico approaches.
• The identification of MiRNA's as biomarkers for screening of cancerous prostates in the early stages an in-silico and molecular method
• Identification of putatively identified the genes present in breast cancer tissues as biomarkers for early detection of lobular and ductal breast cancers.
• Examining the significance of Retinoblastoma Binding Protein 6 (RBBP6) in the regulation of the cancer-related protein Y-Box Binding Protein 1 (YB-1).
• Examining the role played by Retinoblastoma Binding Protein 6 (RBBP6) in the regulation of the cancer suppressor p53 through Mouse Double Minute 2 (MDM2).
• Structural analysis of the anti-oxidant properties of the 1-Cys peroxiredoxin Prx2 found in the plant that resurrects itself Xerophyta viscosa.

Nanotechnology

This is a fascinating aspect of biotechnology, which can be used to identify effective tools to address the most serious health issues.

• Evaluation of cancer-specific peptides to determine their applications for the detection of cancer.
• The development of a quantum dot-based detection systems for breast cancer.
• The creation of targeted Nano-constructs for in vivo imaging as well as the treatment of tumors.
• Novel quinone compounds are being tested as anti-cancer medicines.
• Embedelin is delivered to malignant cells in a specific manner.
• The anti-cancer activities of Tulbaghia Violacea extracts were studied biochemically .
• Novel organic compounds are screened for their anti-cancer potential.
• To treat HIV, nanotechnology-based therapeutic techniques are being developed.

Top 100 Biotechnology Research Proposal Topics to Consider in 2022

We've prepared a list of the top 100 most suggested dissertation topics, which were compiled by our experts in research. They've made sure to offer a an extensive list of topics that cover all aspects of the topic. We hope that this list will meet all of the requirements for assistance with your dissertation . Let us start with our list of subjects, one at a time each one

• Achieving effective control of renewable power technologies to help the village
• The production of ethanol through the aid of molasses and the treatment of its effluent
• Different approaches and aspects of Evapotranspiration
• Its scattering parameter is biotechnology circulator
• The inactivation of mammalian TLR2 via an inhibiting antibody
• The number of proteins produced by Mycobacterium tuberculosis
• Recognition and classification of genes that shape the responses of plants to drought and salinity.
• The small sign molecules that are involved in the response that plants have to the effects of salinity as well as drought
• Genetic improvement of the plant's sensitivity to drought and saltiness
• The pharmacogenomics of drug transporters
• The anti-cancer drugs' pharmacogenomics are based on pharmac
• The pharmacogenomics of antihypertensive medications
• Indels genotyping of African populations
• Genomics of the Y-chromosomes of African populations
• The profiling of DNA extracted from historical crime scenes Consider the implications of South African Innocence Project
• Nanotechnology-related methods for DNA isolation
• Nanotechnology applications in the context of DNA genotyping
• Recognizing the heavy metals that are tolerant with genotypes that are sensitive.
• Genetic characteristics that play a role within the procedure of gaining tolerance to metals
• The animal's DNA is authenticated by the species by the commercial production of raw meat products
• The use of molecular-based technology is in the sense of detection and identification of foodborne pathogens in complicated food systems
• Assessing the effectiveness of cancer-specific peptides that are suitable for efficient implementations in the area of diagnosis and treatment for cancer
• Quantum Dot-based detection system is being developed in relation to a positive breast cancer diagnosis
• It is targeted delivery of the embelin to cancerous cells
• Exploring the potential of novel quinone compounds as anti-cancer agents
• Treatment strategies for treating HIV in addition to the significance of nanotechnology the treatment of HIV.
• A review of the medicinal value the antioxidants found in nature.
• An in-depth examination of the structure of COVID spike proteins
• A review of the immune response to the stem therapy using cells
• CRISPR-Cas9 technology to aid in the process of editing the genome
• Tissue engineering and delivery of drugs through the application of Chitosan
• Evaluation of beneficial effects of cancer vaccines
• Use of PacBio sequencing in relation to genome assembly of model organisms
• Examining the connection between mRNA suppression and its effect on the growth of stem cells
• Biomimicry is a method of identifying of cancer cells
• The sub-classification and characterisation of the Yellow enzymes
• The process of producing food products that are hypoallergenic and fermented.
• The production of hypoallergenic milk
• The purification process for the thermostable phytase
• Bioconversion of the cellulose produce products that are significant for industry
• The investigation of the gut microbiota of the model organisms
• The use of fungal enzymes for the manufacture of chemical glue
• A look at those inhibitors to exocellulase as well as endocellulase
• Examine the value of microorganisms to aid in the recovery of gas from shale.
• Examine the thorough analysis of the method of natural decomposition
• Examine ways to recycle bio-wastes
• Improved bio-remediation in the case of oil spills
• The process of gold biosorption is accomplished with the aid of the cyanobacterium
• A healthy equilibrium between the biotic and the abiotic elements by using biotechnological devices
• The measurement of the mercury level in fish by means of markers
• Exploring the biotechnological capabilities from Jellyfish related microbiomes Jellyfish related microbiome
• What is the role of marine fungi to aid in attempts to break down plastics and polymers?
• Examine the biotechnological possibilities that can be extracted of dinoflagellates
• Removing endosulfan residues using the use of biotechnology the agriculture sector
• The creation of the ELISA method for the detection of crop virus
• Enhancing the quality of drinking water by the aid of the E.coli consortium
• The characterisation of E.coli is its isolation from the feces of Zoo animals
• Enhancing the resistance of crops to the attack of insects
• The reduction of the expenditure on agriculture by using efficient bio-tools
• Are there the most efficient ways to stop erosion of soils using the help of biotechnology-based tools?
• What can biotechnology do to assist in increasing the levels of vitamin content in GM food items?
• Enhancing the distribution of pesticides by using biotechnology
• Comparing the biofortification of folate in various types of corpses
• Examine the photovoltaic-based generation of ocean-based crop
• What is the best way to use nanotechnology will improve the efficiency of the agriculture sector?
• Analyzing the mechanisms that govern resistance to water stresses in models of plants
• Production and testing of human immune boosters within the test organisms
• Comparing genomic analysis to the usefulness of tools intended for bioinformatics
• The Arabinogalactan protein sequence and its value in the field of computational methods
• Analyzing and interpreting gut microbiota from model organisms
• Different methods of purification of proteins A comparative analysis
• The diagnosis of microbes and their function in micro-arrays of oligonucleotide oligonu
• The use of diverse techniques within the biomedical research field that includes micro-arrays technology
• The use of microbial community to produce the greenhouse effect
• Evaluation of the computational properties of various proteins that are derived from the marine microbiota
• E.coli gene mapping through the help of different tools for microbial research
• Intensifying the strains of Cyanobacterium the aid of gene sequencing
• Assessment and description by computation of crystallized proteins that are found in the natural world.
• MTERF protein and the use of it to end the process of transcription that occurs in mitochondrial DNA inside algae
• Reverse column chromatography in phase and its use in the separation of proteins
• The study of the various proteins that are found within Mycobacterium leprae.
• A review of the methods that are ideal to ensure the success of cloning RNA
• Examine the most common mistakes of biotechnology in conserving the ecology and natural environment.
• Is there a method to ensure that the medicinal plants are free of insects? Discuss
• What are the dangers caused by pest resistant animals on birds and human beings?
• What are the many areas of biotechnology that remain unexplored in terms research?
• What's the future of biotechnology in the medical field?
• Recombinant DNA technology to develop of new medical treatments
• What is the reason for the type of bacteria that is used to make vaccines with the aid of biotechnology?
• How can biotechnology aid in the development of new medicines that are resistant to the mutations of viruses and bacteria?
• Is there a long-term treatment for cancer that is available in the near term? Biotechnology could play an essential role in this?
• What is the reason it is so important that students remember the DNA codes in biotechnology?
• How can we create hybrid seeds with assistance of biotechnology?
• How can one create resistant plants to pests and what are the benefits of these seeds in final yields in agriculture?
• Examine bio-magnification and its effects on the ecology
• What are the causes to the reasons ecologists do not approve the use of pest-resistant seed, even though they are in application in agriculture?
• How has biotechnology influenced the lives of farmers in developing countries?
• Biotechnology can be used to boost the yield of plant species?
• Examine the role played by biotechnology to increase the production of the seasonal crops
• Are there any adverse side effects associated with pharmaceutical drugs when they are manufactured with biotechnological techniques? Let the issue with real-world examples

We attempted to cover the essential topics needed for research work. Other topics are available that could be picked based on our interests, the facilities available and resources available for the research, as well as resources and time limits.

We have reached the end of this list. We feel it was beneficial in satisfying the selection criteria. Furthermore, the inclusion of biotechnology-related assignment themes was done in such a manner that they may help us with the requirements of assignment writing kinds and forms. The themes listed above can meet our demands for topic selection linked to aid with case studies and essay assistance, research paper writing help , or thesis writing help .

Frequently asked questions

What are some biotechnology research proposal topics .

Some of biotechnology topics are:

What are the research areas in biotechnology ?

What is best topic for research in biotechnology , what are some examples of biotechnology , what is the scope of biotechnology , what is master in biotechnology , is biotechnology a high paying job , is biotechnology hard to study , is biotechnology a good career , which agecy is best for biotechnology assignment help , can a biotechnologist become a doctor , is biotechnology better than microbiology , is b tech biotechnology a good course .

Top 10 Best Universities Ranking list in India 2022

Generic Conventions: Assignment Help Services

Research Paper Topics For Medical

Top 5 Resources for Writing Excellent Academic Assignments

How to Write a Literature Review for Academic Purposes

Tips for Writing a killer introduction to your assignment

How To Write A Compelling Conclusion For Your University Assignment

Research Papers Topics For Social Science

Best 150 New Research Paper Ideas For Students

7 Best Plagiarism Checkers for Students And Teachers in 2024

Enquiry form.

Biotechnology Research Paper Topics

This collection of biotechnology research paper topics provides the list of 10 potential topics for research papers and overviews the history of biotechnology.

Academic Writing, Editing, Proofreading, And Problem Solving Services

Get 10% off with 24start discount code, 1. animal breeding: genetic methods.

Modern animal breeding relies on scientific methods to control production of domesticated animals, both livestock and pets, which exhibit desired physical and behavioral traits. Genetic technology aids animal breeders to attain nutritional, medical, recreational, and fashion standards demanded by consumers for animal products including meat, milk, eggs, leather, wool, and pharmaceuticals. Animals are also genetically designed to meet labor and sporting requirements for speed and endurance, conformation and beauty ideals to win show competitions, and intelligence levels to perform obediently at tasks such as herding, hunting, and tracking. By the late twentieth century, genetics and mathematical models were appropriated to identify the potential of immature animals. DNA markers indicate how young animals will mature, saving breeders money by not investing in animals lacking genetic promise. Scientists also successfully transplanted sperm-producing stem cells with the goal of restoring fertility to barren breeding animals. At the National Animal Disease Center in Ames, Iowa, researchers created a gene-based test, which uses a cloned gene of the organism that causes Johne’s disease in cattle in order to detect that disease to avert epidemics. Researchers also began mapping the dog genome and developing molecular techniques to evaluate canine chromosomes in the Quantitative Trait Loci (QTL). Bioinformatics incorporates computers to analyze genetic material. Some tests were developed to diagnose many of several hundred genetic canine diseases including hip dysplasia and progressive retinal atrophy (PRA). A few breed organizations modified standards to discourage breeding of genetically flawed animals and promote heterozygosity.

2. Antibacterial Chemotherapy

In the early years of the twentieth century, the search for agents that would be effective against internal infections proceeded along two main routes. The first was a search for naturally occurring substances that were effective against microorganisms (antibiosis). The second was a search for chemicals that would have the same effect (chemotherapy). Despite the success of penicillin in the 1940s, the major early advances in the treatment of infection occurred not through antibiosis but through chemotherapy. The principle behind chemotherapy was that there was a relationship between chemical structure and pharmacological action. The founder of this concept was Paul Erhlich (1854–1915). An early success came in 1905 when atoxyl (an organic arsenic compound) was shown to destroy trypanosomes, the microbes that caused sleeping sickness. Unfortunately, atoxyl also damaged the optic nerve. Subsequently, Erhlich and his co-workers synthesized and tested hundreds of related arsenic compounds. Ehrlich was a co-recipient (with Ilya Ilyich Mechnikov) of the Nobel Prize in medicine in 1908 for his work on immunity. Success in discovering a range of effective antibacterial drugs had three important consequences: it brought a range of important diseases under control for the first time; it provided a tremendous stimulus to research workers and opened up new avenues of research; and in the resulting commercial optimism, it led to heavy postwar investment in the pharmaceutical industry. The therapeutic revolution had begun.

3. Artificial Insemination and in Vitro Fertilization

Artificial insemination (AI) involves the extraction and collection of semen together with techniques for depositing semen in the uterus in order to achieve successful fertilization and pregnancy. Throughout the twentieth century, the approach has offered animal breeders the advantage of being able to utilize the best available breeding stock and at the correct time within the female reproductive cycle, but without the limitations of having the animals in the same location. AI has been applied most intensively within the dairy and beef cattle industries and to a lesser extent horse breeding and numerous other domesticated species.

Many of the techniques involved in artificial insemination would lay the foundation for in vitro fertilization (IVF) in the latter half of the twentieth century. IVF refers to the group of technologies that allow fertilization to take place outside the body involving the retrieval of ova or eggs from the female and sperm from the male, which are then combined in artificial, or ‘‘test tube,’’ conditions leading to fertilization. The fertilized eggs then continue to develop for several days ‘‘in culture’’ until being transferred to the female recipient to continue developing within the uterus.

4. Biopolymers

Biopolymers are natural polymers, long-chained molecules (macromolecules) consisting mostly of a repeated composition of building blocks or monomers that are formed and utilized by living organisms. Each group of biopolymers is composed of different building blocks, for example chains of sugar molecules form starch (a polysaccharide), chains of amino acids form proteins and peptides, and chains of nucleic acid form DNA and RNA (polynucleotides). Biopolymers can form gels, fibers, coatings, and films depending on the specific polymer, and serve a variety of critical functions for cells and organisms. Proteins including collagens, keratins, silks, tubulins, and actin usually form structural composites or scaffolding, or protective materials in biological systems (e.g., spider silk). Polysaccharides function in molecular recognition at cell membrane surfaces, form capsular barrier layers around cells, act as emulsifiers and adhesives, and serve as skeletal or architectural materials in plants. In many cases these polymers occur in combination with proteins to form novel composite structures such as invertebrate exoskeletons or microbial cell walls, or with lignin in the case of plant cell walls.

The use of the word ‘‘cloning’’ is fraught with confusion and inconsistency, and it is important at the outset of this discussion to offer definitional clarification. For instance, in the 1997 article by Ian Wilmut and colleagues announcing the birth of the first cloned adult vertebrate (a ewe, Dolly the sheep) from somatic cell nuclear transfer, the word clone or cloning was never used, and yet the announcement raised considerable disquiet about the prospect of cloned human beings. In a desire to avoid potentially negative forms of language, many prefer to substitute ‘‘cell expansion techniques’’ or ‘‘therapeutic cloning’’ for cloning. Cloning has been known for centuries as a horticultural propagation method: for example, plants multiplied by grafting, budding, or cuttings do not differ genetically from the original plant. The term clone entered more common usage as a result of a speech in 1963 by J.B.S. Haldane based on his paper, ‘‘Biological possibilities for the human species of the next ten-thousand years.’’ Notwithstanding these notes of caution, we can refer to a number of processes as cloning. At the close of the twentieth century, such techniques had not yet progressed to the ability to bring a cloned human to full development; however, the ability to clone cells from an adult human has potential to treat diseases. International policymaking in the late 1990s sought to distinguish between the different end uses for somatic cell nuclear transfer resulting in the widespread adoption of the distinction between ‘‘reproductive’’ and ‘‘therapeutic’’ cloning. The function of the distinction has been to permit the use (in some countries) of the technique to generate potentially beneficial therapeutic applications from embryonic stem cell technology whilst prohibiting its use in human reproduction. In therapeutic applications, nuclear transfer from a patient’s cells into an enucleated ovum is used to create genetically identical embryos that would be grown in vitro but not be allowed to continue developing to become a human being. The resulting cloned embryos could be used as a source from which to produce stem cells that can then be induced to specialize into the specific type of tissue required by the patient (such as skin for burns victims, brain neuron cells for Parkinson’s disease sufferers, or pancreatic cells for diabetics). The rationale is that because the original nuclear material is derived from a patient’s adult tissue, the risks of rejection of such cells by the immune system are reduced.

6. Gene Therapy

In 1971, Australian Nobel laureate Sir F. MacFarlane Burnet thought that gene therapy (introducing genes into body tissue, usually to treat an inherited genetic disorder) looked more and more like a case of the emperor’s new clothes. Ethical issues aside, he believed that practical considerations forestalled possibilities for any beneficial gene strategy, then or probably ever. Bluntly, he wrote: ‘‘little further advance can be expected from laboratory science in the handling of ‘intrinsic’ types of disability and disease.’’ Joshua Lederberg and Edward Tatum, 1958 Nobel laureates, theorized in the 1960s that genes might be altered or replaced using viral vectors to treat human diseases. Stanfield Rogers, working from the Oak Ridge National Laboratory in 1970, had tried but failed to cure argininemia (a genetic disorder of the urea cycle that causes neurological damage in the form of mental retardation, seizures, and eventually death) in two German girls using Swope papilloma virus. Martin Cline at the University of California in Los Angeles, made the second failed attempt a decade later. He tried to correct the bone marrow cells of two beta-thalassemia patients, one in Israel and the other in Italy. What Cline’s failure revealed, however, was that many researchers who condemned his trial as unethical were by then working toward similar goals and targeting different diseases with various delivery methods. While Burnet’s pessimism finally proved to be wrong, progress in gene therapy was much slower than antibiotic or anticancer chemotherapy developments over the same period of time. While gene therapy had limited success, it nevertheless remained an active area for research, particularly because the Human Genome Project, begun in 1990, had resulted in a ‘‘rough draft’’ of all human genes by 2001, and was completed in 2003. Gene mapping created the means for analyzing the expression patterns of hundreds of genes involved in biological pathways and for identifying single nucleotide polymorphisms (SNPs) that have diagnostic and therapeutic potential for treating specific diseases in individuals. In the future, gene therapies may prove effective at protecting patients from adverse drug reactions or changing the biochemical nature of a person’s disease. They may also target blood vessel formation in order to prevent heart disease or blindness due to macular degeneration or diabetic retinopathy. One of the oldest ideas for use of gene therapy is to produce anticancer vaccines. One method involves inserting a granulocyte-macrophage colony-stimulating factor gene into prostate tumor cells removed in surgery. The cells then are irradiated to prevent any further cancer and injected back into the same patient to initiate an immune response against any remaining metastases. Whether or not such developments become a major treatment modality, no one now believes, as MacFarland Burnet did in 1970, that gene therapy science has reached an end in its potential to advance health.

7. Genetic Engineering

The term ‘‘genetic engineering’’ describes molecular biology techniques that allow geneticists to analyze and manipulate deoxyribonucleic acid (DNA). At the close of the twentieth century, genetic engineering promised to revolutionize many industries, including microbial biotechnology, agriculture, and medicine. It also sparked controversy over potential health and ecological hazards due to the unprecedented ability to bypass traditional biological reproduction.

For centuries, if not millennia, techniques have been employed to alter the genetic characteristics of animals and plants to enhance specifically desired traits. In a great many cases, breeds with which we are most familiar bear little resemblance to the wild varieties from which they are derived. Canine breeds, for instance, have been selectively tailored to changing esthetic tastes over many years, altering their appearance, behavior and temperament. Many of the species used in farming reflect long-term alterations to enhance meat, milk, and fleece yields. Likewise, in the case of agricultural varieties, hybridization and selective breeding have resulted in crops that are adapted to specific production conditions and regional demands. Genetic engineering differs from these traditional methods of plant and animal breeding in some very important respects. First, genes from one organism can be extracted and recombined with those of another (using recombinant DNA, or rDNA, technology) without either organism having to be of the same species. Second, removing the requirement for species reproductive compatibility, new genetic combinations can be produced in a much more highly accelerated way than before. Since the development of the first rDNA organism by Stanley Cohen and Herbert Boyer in 1973, a number of techniques have been found to produce highly novel products derived from transgenic plants and animals.

At the same time, there has been an ongoing and ferocious political debate over the environmental and health risks to humans of genetically altered species. The rise of genetic engineering may be characterized by developments during the last three decades of the twentieth century.

8. Genetic Screening and Testing

The menu of genetic screening and testing technologies now available in most developed countries increased rapidly in the closing years of the twentieth century. These technologies emerged within the context of rapidly changing social and legal contexts with regard to the medicalization of pregnancy and birth and the legalization of abortion. The earliest genetic screening tests detected inborn errors of metabolism and sex-linked disorders. Technological innovations in genomic mapping and DNA sequencing, together with an explosion in research on the genetic basis of disease which culminated in the Human Genome Project (HGP), led to a range of genetic screening and testing for diseases traditionally recognized as genetic in origin and for susceptibility to more common diseases such as certain types of familial cancer, cardiac conditions, and neurological disorders among others. Tests were also useful for forensic, or nonmedical, purposes. Genetic screening techniques are now available in conjunction with in vitro fertilization and other types of reproductive technologies, allowing the screening of fertilized embryos for certain genetic mutations before selection for implantation. At present selection is purely on disease grounds and selection for other traits (e.g., for eye or hair color, intelligence, height) cannot yet be done, though there are concerns for eugenics and ‘‘designer babies.’’ Screening is available for an increasing number of metabolic diseases through tandem mass spectrometry, which uses less blood per test, allows testing for many conditions simultaneously, and has a very low false-positive rate as compared to conventional Guthrie testing. Finally, genetic technologies are being used in the judicial domain for determination of paternity, often associated with child support claims, and for forensic purposes in cases where DNA material is available for testing.

9. Plant Breeding: Genetic Methods

The cultivation of plants is the world’s oldest biotechnology. We have continually tried to produce improved varieties while increasing yield, features to aid cultivation and harvesting, disease, and pest resistance, or crop qualities such as longer postharvest storage life and improved taste or nutritional value. Early changes resulted from random crosspollination, rudimentary grafting, or spontaneous genetic change. For centuries, man kept the seed from the plants with improved characteristics to plant the following season’s crop. The pioneering work of Gregor Mendel and his development of the basic laws of heredity showed for other first time that some of the processes of heredity could be altered by experimental means. The genetic analysis of bacterial (prokaryote) genes and techniques for analysis of the higher (eukaryotic) organisms such as plants developed in parallel streams, but the rediscovery of Mendel’s work in 1900 fueled a burst of activity on understanding the role of genes in inheritance. The knowledge that genes are linked along the chromosome thereby allowed mapping of genes (transduction analysis, conjugation analysis, and transformation analysis). The power of genetics to produce a desirable plant was established, and it was appreciated that controlled breeding (test crosses and back crosses) and careful analysis of the progeny could distinguish traits that were dominant or recessive, and establish pure breeding lines. Traditional horticultural techniques of artificial self-pollination and cross-pollination were also used to produce hybrids. In the 1930s the Russian Nikolai Vavilov recognized the value of genetic diversity in domesticated crop plants and their wild relatives to crop improvement, and collected seeds from the wild to study total genetic diversity and use these in breeding programs. The impact of scientific crop breeding was established by the ‘‘Green revolution’’ of the 1960s, when new wheat varieties with higher yields were developed by careful crop breeding. ‘‘Mutation breeding’’— inducing mutations by exposing seeds to x-rays or chemicals such as sodium azide, accelerated after World War II. It was also discovered that plant cells and tissues grown in tissue culture would mutate rapidly. In the 1970s, haploid breeding, which involves producing plants from two identical sets of chromosomes, was extensively used to create new cultivars. In the twenty-first century, haploid breeding could speed up plant breeding by shortening the breeding cycle.

10. Tissue Culturing

The technique of tissue or cell culture, which relates to the growth of tissue or cells within a laboratory setting, underlies a phenomenal proportion of biomedical research. Though it has roots in the late nineteenth century, when numerous scientists tried to grow samples in alien environments, cell culture is credited as truly beginning with the first concrete evidence of successful growth in vitro, demonstrated by Johns Hopkins University embryologist Ross Harrison in 1907. Harrison took sections of spinal cord from a frog embryo, placed them on a glass cover slip and bathed the tissue in a nutrient media. The results of the experiment were startling—for the first time scientists visualized actual nerve growth as it would happen in a living organism—and many other scientists across the U.S. and Europe took up culture techniques. Rather unwittingly, for he was merely trying to settle a professional dispute regarding the origin of nerve fibers, Harrison fashioned a research tool that has since been designated by many as the greatest advance in medical science since the invention of the microscope.

From the 1980s, cell culture has once again been brought to the forefront of cancer research in the isolation and identification of numerous cancer causing oncogenes. In addition, cell culturing continues to play a crucial role in fields such as cytology, embryology, radiology, and molecular genetics. In the future, its relevance to direct clinical treatment might be further increased by the growth in culture of stem cells and tissue replacement therapies that can be tailored for a particular individual. Indeed, as cell culture approaches its centenary, it appears that its importance to scientific, medical, and commercial research the world over will only increase in the twenty-first century.

History of Biotechnology

Biotechnology grew out of the technology of fermentation, which was called zymotechnology. This was different from the ancient craft of brewing because of its thought-out relationships to science. These were most famously conceptualized by the Prussian chemist Georg Ernst Stahl (1659–1734) in his 1697 treatise Zymotechnia Fundamentalis, in which he introduced the term zymotechnology. Carl Balling, long-serving professor in Prague, the world center of brewing, drew on the work of Stahl when he published his Bericht uber die Fortschritte der zymotechnische Wissenschaften und Gewerbe (Account of the Progress of the Zymotechnic Sciences and Arts) in the mid-nineteenth century. He used the idea of zymotechnics to compete with his German contemporary Justus Liebig for whom chemistry was the underpinning of all processes.

By the end of the nineteenth century, there were attempts to develop a new scientific study of fermentation. It was an aspect of the ‘‘second’’ Industrial Revolution during the period from 1870 to 1914. The emergence of the chemical industry is widely taken as emblematic of the formal research and development taking place at the time. The development of microbiological industries is another example. For the first time, Louis Pasteur’s germ theory made it possible to provide convincing explanations of brewing and other fermentation processes.

Pasteur had published on brewing in the wake of France’s humiliation in the Franco–Prussian war (1870–1871) to assert his country’s superiority in an industry traditionally associated with Germany. Yet the science and technology of fermentation had a wide range of applications including the manufacture of foods (cheese, yogurt, wine, vinegar, and tea), of commodities (tobacco and leather), and of chemicals (lactic acid, citric acid, and the enzyme takaminase). The concept of zymotechnology associated principally with the brewing of beer began to appear too limited to its principal exponents. At the time, Denmark was the world leader in creating high-value agricultural produce. Cooperative farms pioneered intensive pig fattening as well as the mass production of bacon, butter, and beer. It was here that the systems of science and technology were integrated and reintegrated, conceptualized and reconceptualized.

The Dane Emil Christian Hansen discovered that infection from wild yeasts was responsible for numerous failed brews. His contemporary Alfred Jørgensen, a Copenhagen consultant closely associated with the Tuborg brewery, published a widely used textbook on zymotechnology. Microorganisms and Fermentation first appeared in Danish 1889 and would be translated, reedited, and reissued for the next 60 years.

The scarcity of resources on both sides during World War I brought together science and technology, further development of zymotechnology, and formulation of the concept of biotechnology. Impending and then actual war accelerated the use of fermentation technologies to make strategic materials. In Britain a variant of a process to ferment starch to make butadiene for synthetic rubber production was adapted to make acetone needed in the manufacture of explosives. The process was technically important as the first industrial sterile fermentation and was strategically important for munitions supplies. The developer, chemist Chaim Weizmann, later became well known as the first president of Israel in 1949.

In Germany scarce oil-based lubricants were replaced by glycerol made by fermentation. Animal feed was derived from yeast grown with the aid of the new synthetic ammonia in another wartime development that inspired the coining of the word biotechnology. Hungary was the agricultural base of the Austro–Hungarian empire and aspired to Danish levels of efficiency. The economist Karl Ereky (1878–1952) planned to go further and build the largest industrial pig-processing factory. He envisioned a site that would fatten 50,000 swine at a time while railroad cars of sugar beet arrived and fat, hides, and meat departed. In this forerunner of the Soviet collective farm, peasants (in any case now falling prey to the temptations of urban society) would be completely superseded by the industrialization of the biological process in large factory-like animal processing units. Ereky went further in his ruminations over the meaning of his innovation. He suggested that it presaged an industrial revolution that would follow the transformation of chemical technology. In his book entitled Biotechnologie, he linked specific technical injunctions to wide-ranging philosophy. Ereky was neither isolated nor obscure. He had been trained in the mainstream of reflection on the meaning of the applied sciences in Hungary, which would be remarkably productive across the sciences. After World War I, Ereky served as Hungary’s minister of food in the short-lived right wing regime that succeeded the fall of the communist government of Bela Kun.

Nonetheless it was not through Ereky’s direct action that his ideas seem to have spread. Rather, his book was reviewed by the influential Paul Lindner, head of botany at the Institut fu¨ r Ga¨ rungsgewerbe in Berlin, who suggested that microorganisms could also be seen as biotechnological machines. This concept was already found in the production of yeast and in Weizmann’s work with strategic materials, which was widely publicized at that very time. It was with this meaning that the word ‘‘Biotechnologie’’ entered German dictionaries in the 1920s.

Biotechnology represented more than the manipulation of existing organisms. From the beginning it was concerned with their improvement as well, and this meant the enhancement of all living creatures. Most dramatically this would include humanity itself; more mundanely it would include plants and animals of agricultural importance. The enhancement of people was called eugenics by the Victorian polymath and cousin of Charles Darwin, Francis Galton. Two strains of eugenics emerged: negative eugenics associated with weeding out the weak and positive eugenics associated with enhancing strength. In the early twentieth century, many eugenics proponents believed that the weak could be made strong. People had after all progressed beyond their biological limits by means of technology.

Jean-Jacques Virey, a follower of the French naturalist Jean-Baptiste de Monet de Lamarck, had coined the term ‘‘biotechnie’’ in 1828 to describe man’s ability to make technology do the work of biology, but it was not till a century later that the term entered widespread use. The Scottish biologist and town planner Patrick Geddes made biotechnics popular in the English-speaking world. Geddes, too, sought to link life and technology. Before World War I he had characterized the technological evolution of mankind as a move from the paleotechnic era of coal and iron to the neotechnic era of chemicals, electricity, and steel. After the war, he detected a new era based on biology—the biotechnic era. Through his friend, writer Lewis Mumford, Geddes would have great influence. Mumford’s book Technics and Civilization, itself a founding volume of the modern historiography of technology, promoted his vision of the Geddesian evolution.

A younger generation of English experimental biologists with a special interest in genetics, including J. B. S. Haldane, Julian Huxley, and Lancelot Hogben, also promoted a concept of biotechnology in the period between the world wars. Because they wrote popular works, they were among Britain’s best-known scientists. Haldane wrote about biological invention in his far-seeing work Daedalus. Huxley looked forward to a blend of social and eugenics-based biological engineering. Hogben, following Geddes, was more interested in engineering plants through breeding. He tied the progressivism of biology to the advance of socialism.

The improvement of the human race, genetic manipulation of bacteria, and the development of fermentation technology were brought together by the development of penicillin during World War II. This drug was successfully extracted from the juice exuded by a strain of the Penicillium fungus. Although discovered by accident and then developed further for purely scientific reasons, the scarce and unstable ‘‘antibiotic’’ called penicillin was transformed during World War II into a powerful and widely used drug. Large networks of academic and government laboratories and pharmaceutical manufacturers in Britain and the U.S. were coordinated by agencies of the two governments. An unanticipated combination of genetics, biochemistry, chemistry, and chemical engineering skills had been required. When the natural mold was bombarded with high-frequency radiation, far more productive mutants were produced, and subsequently all the medicine was made using the product of these man-made cells. By the 1950s penicillin was cheap to produce and globally available.

The new technology of cultivating and processing large quantities of microorganisms led to calls for a new scientific discipline. Biochemical engineering was one term, and applied microbiology another. The Swedish biologist, Carl-Goran Heden, possibly influenced by German precedents, favored the term ‘‘Biotechnologi’’ and persuaded his friend Elmer Gaden to relabel his new journal Biotechnology and Biochemical Engineering. From 1962 major international conferences were held under the banner of the Global Impact of Applied Microbiology. During the 1960s food based on single-cell protein grown in fermenters on oil or glucose seemed, to visionary engineers and microbiologists and to major companies, to offer an immediate solution to world hunger. Tropical countries rich in biomass that could be used as raw material for fermentation were also the world’s poorest. Alcohol could be manufactured by fermenting such starch or sugar rich crops as sugar cane and corn. Brazil introduced a national program of replacing oil-based petrol with alcohol in the 1970s.

It was not, however, just the developing countries that hoped to benefit. The Soviet Union developed fermentation-based protein as a major source of animal feed through the 1980s. In the U.S. it seemed that oil from surplus corn would solve the problem of low farm prices aggravated by the country’s boycott of the USSR in1979, and the term ‘‘gasohol‘‘ came into currency. Above all, the decline of established industries made the discovery of a new wealth maker an urgent priority for Western governments. Policy makers in both Germany and Japan during the 1970s were driven by a sense of the inadequacy of the last generation of technologies. These were apparently maturing, and the succession was far from clear. Even if electronics or space travel offered routes to the bright industrial future, these fields seemed to be dominated by the U.S. Seeing incipient crisis, the Green, or environmental, movement promoted a technology that would depend on renewable resources and on low-energy processes that would produce biodegradable products, recycle waste, and address problems of the health and nutrition of the world.

In 1973 the German government, seeking a new and ‘‘greener’’ industrial policy, commissioned a report entitled Biotechnologie that identified ways in which biological processing was key to modern developments in technology. Even though the report was published at the time that recombinant DNA (deoxyribonucleic acid) was becoming possible, it did not refer to this new technique and instead focused on the use and combination of existing technologies to make novel products.

Nonetheless the hitherto esoteric science of molecular biology was making considerable progress, although its practice in the early 1970s was rather distant from the world of industrial production. The phrase ‘‘genetic engineering’’ entered common parlance in the 1960s to describe human genetic modification. Medicine, however, put a premium on the use of proteins that were difficult to extract from people: insulin for diabetics and interferon for cancer sufferers. During the early 1970s what had been science fiction became fact as the use of DNA synthesis, restriction enzymes, and plasmids were integrated. In 1973 Stanley Cohen and Herbert Boyer successfully transferred a section of DNA from one E. coli bacterium to another. A few prophets such as Joshua Lederberg and Walter Gilbert argued that the new biological techniques of recombinant DNA might be ideal for making synthetic versions of expensive proteins such as insulin and interferon through their expression in bacterial cells. Small companies, such as Cetus and Genentech in California and Biogen in Cambridge, Massachusetts, were established to develop the techniques. In many cases discoveries made by small ‘‘boutique’’ companies were developed for the market by large, more established, pharmaceutical organizations.

Many governments were impressed by these advances in molecular genetics, which seemed to make biotechnology a potential counterpart to information technology in a third industrial revolution. These inspired hopes of industrial production of proteins identical to those produced in the human body that could be used to treat genetic diseases. There was also hope that industrially useful materials such as alcohol, plastics (biopolymers), or ready-colored fibers might be made in plants, and thus the attractions of a potentially new agricultural era might be as great as the implications for medicine. At a time of concern over low agricultural prices, such hopes were doubly welcome. Indeed, the agricultural benefits sometimes overshadowed the medical implications.

The mechanism for the transfer of enthusiasm from engineering fermenters to engineering genes was the New York Stock Exchange. At the end of the 1970s, new tax laws encouraged already adventurous U.S. investors to put money into small companies whose stock value might grow faster than their profits. The brokerage firm E. F. Hutton saw the potential for the new molecular biology companies such as Biogen and Cetus. Stock market interest in companies promising to make new biological entities was spurred by the 1980 decision of the U.S. Supreme Court to permit the patenting of a new organism. The patent was awarded to the Exxon researcher Ananda Chakrabarty for an organism that metabolized hydrocarbon waste. This event signaled the commercial potential of biotechnology to business and governments around the world. By the early 1980s there were widespread hopes that the protein interferon, made with some novel organism, would provide a cure for cancer. The development of monoclonal antibody technology that grew out of the work of Georges J. F. Kohler and Cesar Milstein in Cambridge (co-recipients with Niels K. Jerne of the Nobel Prize in medicine in 1986) seemed to offer new prospects for precise attacks on particular cells.

The fear of excessive regulatory controls encouraged business and scientific leaders to express optimistic projections about the potential of biotechnology. The early days of biotechnology were fired by hopes of medical products and high-value pharmaceuticals. Human insulin and interferon were early products, and a second generation included the anti-blood clotting agent tPA and the antianemia drug erythropoietin. Biotechnology was also used to help identify potential new drugs that might be made chemically, or synthetically.

At the same time agricultural products were also being developed. Three early products that each raised substantial problems were bacteria which inhibited the formation of frost on the leaves of strawberry plants (ice-minus bacteria), genetically modified plants including tomatoes and rapeseed, and the hormone bovine somatrotropin (BST) produced in genetically modified bacteria and administered to cattle in the U.S. to increase milk yields. By 1999 half the soy beans and one third of the corn grown in the U.S. were modified. Although the global spread of such products would arouse the best known concern at the end of the century, the use of the ice-minus bacteria— the first authorized release of a genetically engineered organism into the environment—had previously raised anxiety in the U.S. in the 1980s.

In 1997 Dolly the sheep was cloned from an adult mother in the Roslin agricultural research institute outside Edinburgh, Scotland. This work was inspired by the need to find a way of reproducing sheep engineered to express human proteins in their milk. However, the public interest was not so much in the cloning of sheep that had just been achieved as in the cloning of people, which had not. As in the Middle Ages when deformed creatures had been seen as monsters and portents of natural disasters, Dolly was similarly seen as monster and as a portent of human cloning.

The name Frankenstein, recalled from the story written by Mary Shelley at the beginning of the nineteenth century and from the movies of the 1930s, was once again familiar at the end of the twentieth century. Shelley had written in the shadow of Stahl’s theories. The continued appeal of this book embodies the continuity of the fears of artificial life and the anxiety over hubris. To this has been linked a more mundane suspicion of the blending of commerce and the exploitation of life. Discussion of biotechnology at the end of the twentieth century was therefore colored by questions of whose assurances of good intent and reassurance of safety could be trusted.

Browse other Technology Research Paper Topics .

ORDER HIGH QUALITY CUSTOM PAPER

More From Forbes

Emerging trends in ai in biotech.

• Share to Facebook
• Share to Twitter
• Share to Linkedin

CEO & Founder, Healr Solutions ​​​​​​​ | MIT Senior Lecturer | Corporate, Non-Profit, & Governmental Board Member.

The intersection of artificial intelligence (AI) and biotechnology is revolutionizing the healthcare landscape, offering opportunities for venture capitalists (VCs) to drive innovation and achieve significant returns on investment. This article delves into the key trends in AI in biotech and provides actionable strategies for VCs to navigate this dynamic sector.

As an executive leading biotech research and a founder of a biotech, I've witnessed firsthand the transformative potential of AI in this field. Additionally, my tenure as a researcher at the Robert Langer Lab at MIT, where I focused on drug discovery, and my role teaching bioethics and biotech business at MIT have given me a comprehensive understanding of the sector's intricacies.

It is crucial to explore these developments now because AI is at a pivotal point in its capacity to create new products that can significantly enhance individuals' health and well-being.

Personalized Medicine

Personalized medicine represents a shift from a one-size-fits-all approach to tailored treatments based on individual genetic profiles, lifestyles and environments. AI algorithms are central to this transformation, enabling the analysis of vast data to predict patient responses to treatments, thus enhancing efficacy and reducing adverse effects. Companies at the forefront of AI-driven personalized medicine , such as Tempus and Foundation Medicine, are developing platforms that offer custom cancer therapies, personalized treatment plans for rare diseases, and precision pharmacogenomics.

AI-Driven Drug Discovery

The traditional drug discovery process is time-consuming and costly, often taking over a decade and billions of dollars to bring a new drug to market. AI is streamlining this process by predicting the efficacy and safety of potential compounds with more speed and accuracy. AI models can analyze chemical databases to identify new drug candidates or repurpose existing drugs for new therapeutic uses. Companies leading the trend in drug discovery include Insilco Medicine and Atomwise. This trend is particularly promising for addressing unmet medical needs and accelerating the development of treatments for complex diseases.

Synthetic Biology

Companies are harnessing AI for gene editing, biomaterial production and synthetic pathways are at the forefront of synthetic biology. This combines principles of biology and engineering to design and construct new biological entities. AI optimizes synthetic biology processes , from designing genetic circuits to scaling up production. For example, Ginkgo Bioworks uses AI to design custom microorganisms for applications ranging from pharmaceuticals to industrial chemicals.

Regenerative Medicine

AI is transforming regenerative medicine by advancing the development of stem cell therapies and tissue engineering. AI algorithms assist in identifying optimal cell types, predicting cell behavior and personalized treatments, which is particularly relevant for conditions such as neurodegenerative diseases, heart failure and orthopedic injuries. Organovo, for instance, is leveraging AI to potentially improve the efficacy and scalability of regenerative therapies, developing next-generation treatments that offer the potential to restore function and improve the quality of life for patients.

Data Integration

One of the biggest challenges in healthcare is the integration of disparate data sources, including genomic, proteomic and clinical data. For AI to deliver meaningful insights, seamless data integration and interoperability are critical. Startups developing platforms facilitating comprehensive, longitudinal patient data analysis are vital enablers of AI in biotech. Companies like Flatiron Health are working on integrating diverse datasets to provide a holistic view of patient health, enabling more accurate diagnoses and personalized treatment plans. VCs should prioritize investments in companies that break down data silos and promote data interoperability, as this will enhance the utility and impact of AI-driven solutions.

Strategies For VCs

Focus on clinical validation..

Look at companies that prioritize clinical validation of their AI technologies. Clinical trials and real-world evidence not only enhance credibility but also accelerate market adoption. For example, Novartis’ CAR-T therapy, Kymriah, received the FDA’s accelerated approval for treating relapsed or refractory follicular lymphoma, thanks to the integration of real-world evidence (RWE) with clinical trials data from the Phase II ELARA trial. VCs should look for companies with robust clinical trial data and partnerships with leading healthcare institutions. This focus on validation ensures that the technologies being developed are innovative, clinically relevant and ready for deployment in real-world settings.

Foster collaborative ecosystems.

Encourage portfolio companies to build partnerships with academic institutions, healthcare providers and pharmaceutical companies to foster a collaborative ecosystem that accelerates research and development. These partnerships can provide access to valuable resources, including clinical data, research expertise and regulatory insights. For instance, companies like IBM Watson Health have formed strategic alliances with academic medical centers to enhance their AI-driven healthcare solutions. Through this practice, VCs can help their portfolio companies leverage external expertise and resources to advance their technologies and achieve commercial success.

Emphasize ethical AI.

To build trust and mitigate regulatory and public scrutiny risks, companies should prioritize transparency, accountability and fairness in their AI algorithms. This includes addressing patient privacy, data security, and algorithmic bias issues. VCs should seek companies with clear ethical guidelines and robust data governance frameworks. For example, companies like Google Health and Microsoft are known for their commitment to ethical AI practices, which enhances their reputation and market acceptance.

Support scalable solutions.

VCs should focus on companies that develop scalable solutions that can be easily integrated into existing healthcare infrastructures. Scalable innovations ensure broader adoption and maximize return on investment. Digitally transformed incumbents—those leveraging digital technologies to compete innovatively and those venturing into new industries digitally—are twice as likely to achieve outstanding financial growth compared to their traditional counterparts, as shown by a McKinsey study. VCs should assess the scalability potential of AI platforms, considering factors such as compatibility with existing systems, ease of implementation and cost-effectiveness. Companies that offer modular and flexible solutions, such as cloud-based platforms and API integrations, are well-positioned to scale their technologies and achieve widespread market penetration.

The fusion of AI and biotechnology presents a wealth of opportunities for venture capitalists. By staying attuned to emerging trends and adopting strategies for impactful investments, VCs can drive innovation and create transformative changes in healthcare.

Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?

• Editorial Standards
• Reprints & Permissions

• Frontiers in Sustainable Food Systems
• Sustainable Food Processing
• Research Topics

Trends in Sustainable Food Processing: Proceedings from the Fourth International Biotechnology Congress, BioIberoamerica

Total Downloads

Total Views and Downloads

About this Research Topic

This Research Topic is linked with the Fourth BioIberoamerica conference on Biotechnology, which will be held from September 3 to 6 in the city of Monterrey, Nuevo León, Mexico. We have dedicated this Research Topic to trends in sustainable food bioprocessing with innovative approaches through the sustainable utilization and management of bioresources from local and global perspectives. This Research Topic aims to include the best selected papers of the International Biotechnology Congress, BioIberoamerica 2024. We invite authors to submit original research papers or review articles to Frontiers in Sustainable Food Systems in the Sustainable Food Processing section. All manuscripts will go through a rigorous review process before being published as open access articles. We invite manuscripts addressing but not limited to the following: - Valorization of agroindustrial waste - Biological Processing of Biomass - New bioreactors for food processing - Novel biocatalysts for food processing - Biodegradation and biodeterioration - Food Biotechnology and Product Development - Natural Products used for Sustainable Food processing - Biodegradable materials in the context of food processing

Keywords : Food Processing, Conferences, Sustainability, Biotechnology, Agroindustrial Waste, Biodegradation, Biodeterioration

Important Note : All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Topic coordinators, submission deadlines.

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

total views

• Demographics

No records found

total views article views downloads topic views

Top countries

Top referring sites, about frontiers research topics.

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Hot Research Topics in Biotech in 2022

The past few years years have seen leaps and strides of innovation as scientists have worked to develop and produce new mRNA vaccinations and made major developments in biotech research. During this time, they’ve also faced challenges. Ongoing supply chain disruptions , the Great Resignation, and the pandemic have impacted biotech labs and researchers greatly, forcing lab managers and PIs to get creative with lab supply purchasing, experiment planning, and the use of technology in order to maintain their research schedules.

“The pace of innovation specific to COVID to be able to develop both medicines related to antibodies as well as vaccines is just staggering. Those of us in the industry are in awe of the innovation we’re witnessing on a daily basis. We’ve been behind in the use of automation, software, and AI that can make our industry more efficient — that’s where we’re headed,” says Michelle Dipp, Cofounder and Managing Partner, Biospring Partners on the This is ZAGENO podcast .

At the start of 2022, current biotech research projects are exploring advancements in medicine, vaccines, the human body and treatment of disease, bacteria and immunology, and viruses like the Coronavirus that affected the globe in ways we couldn’t have anticipated.

Biotech Research Processes are Changing

As Michelle explained, the research that’s happening is changing, and so is the way that scientists conduct it. Influenced by both B2C ecommerce and the growing dependence on remote and cloud-based working, biotech labs are undergoing digital transformations . This means more software, AI, and automation in the lab, along with modern digital procurement strategies and integrated systems for lab operations.

Here are some of the top biotech research trends and recent biotech research papers that are changing the world of science and leading to innovation in life sciences.

Top 6 Biotech Research Topics for 2022

Science journals have never been more popular as they’ve been in the past several years. Resonating with the general public, biotech research papers have found their way into the hands and social media streams of interested citizens and scientists alike.

As we look to the most credible, peer-reviewed sources for recent innovations like PubMed , the Journal of Biotechnology , BioTech , and Biotechnology Journal , the trending themes in biotech research are in direct response to COVID-19, like vaccine development, respiratory virus research, and RNA-based pharmaceuticals. Additionally, there have been major advances in metabolism and the human microbiome, as well as further exploration in microvesicles.

All of the research happening has the potential to change millions of people’s quality of life, prevent and treat illnesses that currently have high mortality rates, and change healthcare around the world.

Here's what's happening in biotech research.

1. Vaccine Development mRNA vaccine development has been in the works since 1989 and was accelerated in recent years to combat the global COVID-19 pandemic. Researchers like Maruggi, Zhang, Li, Ulmer, Yu and their team believe that mRNA vaccines could change infectious disease control as we know it as a prophylactic means of disease prevention for diseases like HIV, Zika, and the flu.

Recent developments in mRNA research from Pardi, Hogan, and Weissman in 2020 explored the ways that mRNA vaccines can combat certain cancers and infectious pathogens that were previously resistant to existing vaccine options.

With new access to data from the 3.4 billion+ COVID-19 mRNA vaccines that have been administered worldwide, researchers have been able to determine the risks associated with mRNA vaccines , which brings forward new topics for research in the medical and pharmaceutical sides of the biotech industry. mRNA vaccines are faster to develop and can help prevent more diseases than traditional vaccine methods.

2. Respiratory Viruses Acute respiratory diseases (ARDs) like those caused by the SARS-CoV pathogen or the influenza virus lead to morbidity and mortality, and can lead to pneumonia, which can be fatal for immunocompromised or elderly patients — they represent a huge impact to human society.

Identifying the cause of ARDs and identifying viral infections from COVID-19 has become an issue of public health and safety, leading research groups like Zhang, Wang, and team to seek out more accurate and faster ways to detect respiratory viruses .

Understanding these respiratory virus mechanisms can help lead to better protection, prevention, and treatments for respiratory viruses, which have a mortality rate of up to 78% .

3. RNA-based Therapeutics RNA-based treatments like modified non-coding RNAs (ncRNAs), microRNAs (miRNAs), and others have been developed and studied by teams like Feng, Patil, et al (2021) to treat various diseases and conditions, including pancreatic cancer, acute renal failure, acute kidney injuries, diabetic macular edema, and advanced solid tumors.

In 2022, we expect to see further development of RNA-based therapeutics, like CAR T cells and other gene/cell therapeutics, therapeutic antibodies, and small molecular drugs to treat even more diseases and for prophylactic purposes as well.

4. Microvesicles + Extracellular Vesicles Microvesicles are coming to light due to their involvement in transporting mRNA, miRNA, and proteins — but how else might they support the human body? There are unknown functions of microvesicles and other extracellular vesicles that have yet to be discovered.

In 2020, Ratajczak and Ratajczak found that understanding microvesicles (or exosomes, microparticles) could mean understanding cell-to-cell communication , and their research showed that extracellular vesicles could transfer mRNA and proteins and modify stem cells ex vivo. This year, we look forward to seeing more research on what these tiny cell parts can do.

5. Metabolism in Cancers + Other Diseases Metabolism is the process of energy conversion in organisms and it represents the chemical reactions that sustain life. Recent research on metabolism in cancers and in immune cells has uncovered new ways to approach treatment and prevention of certain illnesses.

Take a look at Matsushita, Nakagawa, and Koike’s (2021) research on lipid metabolism in oncology and how recent advances in lipidomics technology and mass spectrometry have opened the door for new analysis of lipid profiles of certain cancers.

6. The Human Microbiome The human microbiome hosts bacteria, microorganisms, and other naturally-occurring flora that can help us and harm us. Diet, stress, drugs, and other factors shape the microbiome, leading to inflammation and an immune response of cytokines. Recent machine learning and statistical analyses of microbiome data , like that of Indias, Lahti, Nedyalkova, and team (2021) are getting smarter and smarter by removing variables and providing ways to test new hypotheses using statistical modeling.

With a deeper understanding of the microbiome, researchers like David Sinclair have shown that lifestyle changes can actually help people live healthier lives for longer . Sinclair’s lab is at the forefront of aging research and its impact on healthcare — and it’s all rooted in biotechnology and life science experiments.

Recent updates to ICD-11 and its classification of aging as a disease have led to debate, with Sinclair and colleagues advocating for the ongoing paradigm shift that biological age and chronological age are not synonymous. The implications for longevity and aging research from a funding perspective will be impacted by WHO and NIH decisions, and we anticipate seeing more biotech research on topics like epigenetics, metabolism, mitochondrial dysfunction, reproduction, and stem cell developments in the coming years.

Biotech research can change humankind, and lead to a better quality of life for generations to come. Subscribe to the ZAGENO blog to keep up with the latest topics in biotech and life sciences research and find the tech that supports biotech lab managers and PIs in their ongoing work.

All your lab needs in one place

Access 40,000,000 products in one shop!

Trusted by thousands of scientists, lab managers, procurement and finance teams, ZAGENO's marketplace will help you search and order quickly in one go. Reach out for a demo today!

5 Methods for Conducting Agile Biotech Research

Top Books for Biotech Founders

Biotech Accelerator, Incubator, and Lab Share: What’s the Difference?

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• Explore content
• About the journal
• Publish with us
• Sign up for alerts

Review Articles

Epigenome editing technologies for discovery and medicine

Epigenome editing has versatile applications in biomedical research and disease treatment.

• Sean R. McCutcheon
• Dahlia Rohm
• Charles A. Gersbach

Sparks of function by de novo protein design

Chu and colleagues discuss recent developments in de novo protein design.

• Alexander E. Chu
• Po-Ssu Huang

Machine learning for functional protein design

Notin, Rollins and colleagues discuss advances in computational protein design with a focus on redesign of existing proteins.

• Pascal Notin
• Nathan Rollins
• Debora Marks

Computational drug development for membrane protein targets

Drug discovery is being transformed by advances in computational protein structure prediction and protein design.

• Xiaolin Sun
• Horst Vogel

Soil microbiome engineering for sustainability in a changing environment

Challenges and opportunities for engineering and studying the soil microbiome are discussed.

• Janet K. Jansson
• Ryan McClure
• Robert G. Egbert

Precision RNA base editing with engineered and endogenous effectors

Pfeiffer and Stafforst review and discuss the state-of-the-art tools for precision editing of RNA bases.

• Laura S. Pfeiffer
• Thorsten Stafforst

Unlocking the promise of mRNA therapeutics

mRNA therapeutics face more challenges than mRNA vaccines, but solutions are on the horizon.

• Eduarde Rohner
• Kenneth R. Chien

The expanding vistas of spatial transcriptomics

Spatial transcriptomics workflows, metrics and limitations are reviewed and discussed.

• Evan Z. Macosko

Prediction of peptide mass spectral libraries with machine learning

Proteomics is being transformed by deep learning methods that predict peptide fragmentation spectra.

Smartphone apps in the COVID-19 pandemic

An overview of apps for outbreak epidemiology, individual screening and contact tracing during the COVID-19 pandemic.

• Jay A. Pandit
• Jennifer M. Radin
• Eric J. Topol

The clinical progress of mRNA vaccines and immunotherapies

Anderson and colleagues discuss the progress and challenges of using mRNA for vaccines and immunotherapy.

• Ann J. Barbier
• Allen Yujie Jiang
• Daniel G. Anderson

Spatial components of molecular tissue biology

Regev, Theis and colleagues outline the challenges and concepts of the analysis of spatial transcriptomics data.

• Giovanni Palla
• David S. Fischer
• Fabian J. Theis

Single-cell immunology of SARS-CoV-2 infection

This Review provides an overview of existing studies using single-cell technologies to provide insights over the immune responses and molecular mechanisms at work in COVID-19.

• Lindsay N. Carpp
• Raphael Gottardo

Nanopore sequencing technology, bioinformatics and applications

Au and colleagues outline the field of nanopore sequencing.

• Yunhao Wang

Identification of tumor antigens with immunopeptidomics

Chong et al. review how the integration of mass spectrometry with proteogenomic approaches can identify noncanonical antigens.

• Chloe Chong
• George Coukos
• Michal Bassani-Sternberg

Computational principles and challenges in single-cell data integration

As the number of single-cell experiments with multiple data modalities increases, Argelaguet and colleagues review the concepts and challenges of data integration.

• Ricard Argelaguet
• Anna S. E. Cuomo
• John C. Marioni

The delivery challenge: fulfilling the promise of therapeutic genome editing

As CRISPR therapies move into clinical testing, David Schaffer and colleagues review a raft of different delivery technologies being road tested to address cargo capacity limitations, maximize potency, minimize off-target effects and avoid immunogenicity.

• Joost van Haasteren
• David V. Schaffer

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors

A growing arsenal of CRISPR-based tools enables increasingly sophisticated genome editing applications.

• Andrew V. Anzalone
• Luke W. Koblan
• David R. Liu

Design and analysis of CRISPR–Cas experiments

Hanna and Doench review the computational methods and tools that have become indispensable for planning and analyzing CRISPR experiments.

• Ruth E. Hanna
• John G. Doench

Probing and engineering liquid-phase organelles

Engineering and manipulating phase-separated liquid organelles is the latest frontier in the quest to mimic and interrogate living systems at the molecular level.

• Mackenzie T. Walls
• Clifford P. Brangwynne

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

• Research & Faculty
• Offices & Services
• Information for:
• Faculty & Staff
• News & Events
• Contact & Visit
• Student Resources
• Curriculum Overview
• Course Schedules
• Minors and Certificates
• Nanobiotechnology
• Course Listings
• Student Research Overview
• Research Areas
• Biomaterials
• Cancer Biotechnology
• Cardiovascular Biology & Transplantation Biology
• Cell & Molecular Biology
• Developmental Biology & Neurobiology
• Diagnostics & Medical Devices
• Drug Discovery & Delivery
• Microbial & Environmental Biotechnology
• Stem Cell Biology
• Sustainability & Global Health Biotechnology
• Synthetic & Systems Biology
• Research Papers
• Admissions Overview
• Information Sessions
• Core Faculty and Staff
• Adjunct Faculty and Staff
• Research Advisors
• Current Students
• Association of Biotechnology Students
• Industrial Advisory Board
• Program Benefactors
• Class of 2021
• Class of 2020
• Class of 2019
• Class of 2018
• Class of 2017
• Class of 2016
• Class of 2015
• Class of 2014
• Class of 2013
• Class of 2012
• Class of 2011
• Class of 2010
• Class of 2009
• Class of 2008
• Class of 2007
• Class of 2006
• Class of 2005
• Class of 2004
• Career Development
• Co-op / Internship
• Where to Work in Biotech
• Philadelphia
• Research Triangle
• San Francisco
• Washington D.C.
• Stories Archive
• Seminars & Events
• Upcoming Events
• Biotech Nexus
• Site Visits
• Northwestern Engineering

Student Research Student Research Areas

The research projects listed on our alumni webpages are meant to illustrate the diversity and number of research possibilities that the MBP has to offer. Research projects naturally evolve over time: some continue, while others get terminated based on research advisors' interests and funding opportunities. However, the MBP ensures that each of the 12 areas of research listed on our website continue to be adequately represented by research projects.

• Cardiovascular Biology and Transplantation Biology
• Cell and Molecular Biology
• Developmental Biology and Neurobiology
• Diagnostics and Medical Devices
• Drug Discovery and Delivery
• Microbial and Environmental Biotechnology
• Sustainability and Global Health Biotechnology
• Synthetic and Systems Biology

More in this section

• Engineering Home
• MBP Program
• Student Research

How To Apply

Contact info.

Master of Biotechnology Program Northwestern University Tech Institute, A334 2145 Sheridan Road Evanston, Illinois 60208 Phone: 847-467-3365 Email the program

Request Info

Request your program & application guide.

Surge in young people claiming disability benefits, research suggests

More than 682,000 young people received the Child Disability Living Allowance (DLA) in 2023, up from 333,000 in 2013.

Saturday 17 August 2024 13:12, UK

The number of young people claiming disability benefits has doubled over the past decade, a new study has shown.

Across England and Wales, 1.2 million children are living with a disability, with the most significant increase among teenagers, the research from the Resolution Foundation found.

The report noted young people aged 15-16 were more likely than adults in their 20s, 30s or 40s to receive a disability benefit, only surpassed by those aged 52 and older.

Four in five children receiving the Child DLA had been diagnosed with a learning difficulty, behavioural disorder, or attention deficit hyperactivity disorder (ADHD), the thinktank said.

Louise Murphy, Resolution Foundation senior economist and author of the report, told Sky News there has been a "huge shift" over the past decade in the number of young people who receive the benefit.

She said: "Certainly over the past decade or so, there has been a change in how we speak about and label certain conditions.

More on Benefits

Winter fuel payment changes - are you still eligible?

Labour two-child benefit cap rebels 'totally out of order', says Harriet Harman

What is the two-child benefit cap?

Related Topics:

"I don't think we need to deny that, but I think what is important to remember is that regardless of some of these societal shifts, this disability, this prevalence of disability, is definitely real.

"It's having impacts on how people live their lives, feel about their lives. It's having impacts on the benefits system, and it is showing up in some quite concrete measures."

Keep up with all the latest news from the UK and around the world by following Sky News

Ms Murphy added: "For example, the number of children being prescribed medication for ADHD and for conditions like anxiety and depression has increased quite significantly.

"And we've seen some quite troubling trends. For example, an increase in the number of children being admitted to hospital in relation to self-harm.

"So, it's certainly real and it's not just about kind of different language."

Read more from Sky News: What is the two-child benefit cap? Winter fuel payment changes - are you still eligible?

The figures also revealed the number of people claiming disability benefits dropped by more than a quarter as people transitioned from children's disability allowances to adult schemes.

Ms Murphy said: "There may be positive reasons for no longer claiming support, but it is a huge worry if young people are leaving the benefits system and missing out on support at the arbitrary cut-off point of age 16, rather than when their condition changes."

Be the first to get Breaking News

Install the Sky News app for free

Data also revealed the percentage of 15-year-olds with a disability increased from 10% to 17% over the last decade, a sharper increase than among young children or the broader working population.

Ms Murphy said: "It is understandable that politicians want to reduce the rise in disability benefit spending. But to do that they will need to understand and address the root causes of rising disability among children."

Related Topics

Aims and scope

3 Biotech publishes the results of the latest research related to the study and application of biotechnology to: - Medicine and Biomedical Sciences - Agriculture - The Environment The focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech appeals to scientists and engineers in both academia and industry focusing on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment. Articles from a huge variety of biotechnology applications are welcome including: - Cancer and stem cell research - Genetic engineering and cloning - Bioremediation and biodegradation - Bioinformatics and system biology - Biomarkers and biosensors - Biodiversity and biodiscovery - Biorobotics and biotoxins - Analytical biotechnology and the human genome 3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance. 3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including: - Science Citation Index Expanded - Journal Citation Reports/Science Edition - Biological Abstracts - BIOSIS Previews 3 Biotech publishes under the Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a waiting line. This will ensure that all articles in 3 Biotech are immediately available for researchers in relevant indexing and abstracting databases.

• Find a journal
• Publish with us
• Track your research

Suggestions or feedback?

MIT News | Massachusetts Institute of Technology

• Machine learning
• Sustainability
• Black holes
• Classes and programs

Departments

• Aeronautics and Astronautics
• Brain and Cognitive Sciences
• Architecture
• Political Science
• Mechanical Engineering

Centers, Labs, & Programs

• Abdul Latif Jameel Poverty Action Lab (J-PAL)
• Picower Institute for Learning and Memory
• Lincoln Laboratory
• School of Architecture + Planning
• School of Engineering
• School of Humanities, Arts, and Social Sciences
• Sloan School of Management
• School of Science
• MIT Schwarzman College of Computing

3 Questions: How to prove humanity online

Press contact :, media download.

*Terms of Use:

Images for download on the MIT News office website are made available to non-commercial entities, press and the general public under a Creative Commons Attribution Non-Commercial No Derivatives license . You may not alter the images provided, other than to crop them to size. A credit line must be used when reproducing images; if one is not provided below, credit the images to "MIT."

Previous image Next image

As artificial intelligence agents become more advanced, it could become increasingly difficult to distinguish between AI-powered users and real humans on the internet. In a new white paper , researchers from MIT, OpenAI, Microsoft, and other tech companies and academic institutions propose the use of personhood credentials, a verification technique that enables someone to prove they are a real human online, while preserving their privacy.

MIT News spoke with two co-authors of the paper, Nouran Soliman, an electrical engineering and computer science graduate student, and Tobin South, a graduate student in the Media Lab, about the need for such credentials, the risks associated with them, and how they could be implemented in a safe and equitable way.

Q:  Why do we need personhood credentials?

Tobin South:  AI capabilities are rapidly improving. While a lot of the public discourse has been about how chatbots keep getting better, sophisticated AI enables far more capabilities than just a better ChatGPT, like the ability of AI to interact online autonomously. AI could have the ability to create accounts, post content, generate fake content, pretend to be human online, or algorithmically amplify content at a massive scale. This unlocks a lot of risks. You can think of this as a “digital imposter” problem, where it is getting harder to distinguish between sophisticated AI and humans. Personhood credentials are one potential solution to that problem.

Nouran Soliman: Such advanced AI capabilities could help bad actors run large-scale attacks or spread misinformation. The internet could be filled with AIs that are resharing content from real humans to run disinformation campaigns. It is going to become harder to navigate the internet, and social media specifically. You could imagine using personhood credentials to filter out certain content and moderate content on your social media feed or determine the trust level of information you receive online.

Q:  What is a personhood credential, and how can you ensure such a credential is secure?

South:  Personhood credentials allow you to prove you are human without revealing anything else about your identity. These credentials let you take information from an entity like the government, who can guarantee you are human, and then through privacy technology, allow you to prove that fact without sharing any sensitive information about your identity. To get a personhood credential, you are going to have to show up in person or have a relationship with the government, like a tax ID number. There is an offline component. You are going to have to do something that only humans can do. AIs can’t turn up at the DMV, for instance. And even the most sophisticated AIs can’t fake or break cryptography. So, we combine two ideas — the security that we have through cryptography and the fact that humans still have some capabilities that AIs don’t have — to make really robust guarantees that you are human.

Soliman:  But personhood credentials can be optional. Service providers can let people choose whether they want to use one or not. Right now, if people only want to interact with real, verified people online, there is no reasonable way to do it. And beyond just creating content and talking to people, at some point AI agents are also going to take actions on behalf of people. If I am going to buy something online, or negotiate a deal, then maybe in that case I want to be certain I am interacting with entities that have personhood credentials to ensure they are trustworthy.

South:  Personhood credentials build on top of an infrastructure and a set of security technologies we’ve had for decades, such as the use of identifiers like an email account to sign into online services, and they can complement those existing methods.

Q:  What are some of the risks associated with personhood credentials, and how could you reduce those risks?

Soliman:  One risk comes from how personhood credentials could be implemented. There is a concern about concentration of power. Let’s say one specific entity is the only issuer, or the system is designed in such a way that all the power is given to one entity. This could raise a lot of concerns for a part of the population — maybe they don’t trust that entity and don’t feel it is safe to engage with them. We need to implement personhood credentials in such a way that people trust the issuers and ensure that people’s identities remain completely isolated from their personhood credentials to preserve privacy.

South:  If the only way to get a personhood credential is to physically go somewhere to prove you are human, then that could be scary if you are in a sociopolitical environment where it is difficult or dangerous to go to that physical location. That could prevent some people from having the ability to share their messages online in an unfettered way, possibly stifling free expression. That’s why it is important to have a variety of issuers of personhood credentials, and an open protocol to make sure that freedom of expression is maintained.

Soliman:  Our paper is trying to encourage governments, policymakers, leaders, and researchers to invest more resources in personhood credentials. We are suggesting that researchers study different implementation directions and explore the broader impacts personhood credentials could have on the community. We need to make sure we create the right policies and rules about how personhood credentials should be implemented.

South: AI is moving very fast, certainly much faster than the speed at which governments adapt. It is time for governments and big companies to start thinking about how they can adapt their digital systems to be ready to prove that someone is human, but in a way that is privacy-preserving and safe, so we can be ready when we reach a future where AI has these advanced capabilities. 

Share this news article on:

Related links.

• Nouran Soliman
• Tobin South
• Computer Science and Artificial Intelligence Laboratory
• Department of Electrical Engineering and Computer Science
• School of Architecture and Planning

Related Topics

• Artificial intelligence
• Cybersecurity
• Social media
• Social networks
• Computer Science and Artificial Intelligence Laboratory (CSAIL)
• Electrical Engineering & Computer Science (eecs)

Related Articles

3 Questions: What you need to know about audio deepfakes

MIT group releases white papers on governance of AI

What does the future hold for generative AI?

MIT professor to Congress: “We are at an inflection point” with AI

Previous item Next item

More MIT News

When the lights turned on in the universe

Read full story →

Lincoln Laboratory and National Strategic Research Institute launch student research program to tackle biothreats to national security

Christine Ortiz named director of MIT Technology and Policy Program

MIT engineers design tiny batteries for powering cell-sized robots

New open-source tool helps to detangle the brain

LLMs develop their own understanding of reality as their language abilities improve

• More news on MIT News homepage →

Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA, USA

• Map (opens in new window)
• Events (opens in new window)
• People (opens in new window)
• Careers (opens in new window)
• Accessibility
• Social Media Hub
• MIT on Facebook
• MIT on YouTube
• MIT on Instagram

• Mobile Site
• Staff Directory
• Advertise with Ars

Filter by topic

• Biz & IT
• Gaming & Culture

Front page layout

self-preservation without replication —

Research ai model unexpectedly modified its own code to extend runtime, facing time constraints, sakana's "ai scientist" attempted to change limits placed by researchers..

Benj Edwards - Aug 14, 2024 8:13 pm UTC

On Tuesday, Tokyo-based AI research firm Sakana AI announced a new AI system called " The AI Scientist " that attempts to conduct scientific research autonomously using AI language models (LLMs) similar to what powers ChatGPT . During testing, Sakana found that its system began unexpectedly attempting to modify its own experiment code to extend the time it had to work on a problem.

Further Reading

"In one run, it edited the code to perform a system call to run itself," wrote the researchers on Sakana AI's blog post. "This led to the script endlessly calling itself. In another case, its experiments took too long to complete, hitting our timeout limit. Instead of making its code run faster, it simply tried to modify its own code to extend the timeout period."

Sakana provided two screenshots of example Python code that the AI model generated for the experiment file that controls how the system operates. The 185-page AI Scientist research paper discusses what they call "the issue of safe code execution" in more depth.

• A screenshot of example code the AI Scientist wrote to extend its runtime, provided by Sakana AI. Sakana AI

While the AI Scientist's behavior did not pose immediate risks in the controlled research environment, these instances show the importance of not letting an AI system run autonomously in a system that isn't isolated from the world. AI models do not need to be "AGI" or "self-aware" (both hypothetical concepts at the present) to be dangerous if allowed to write and execute code unsupervised. Such systems could break existing critical infrastructure or potentially create malware, even if unintentionally.

Sakana AI addressed safety concerns in its research paper, suggesting that sandboxing the operating environment of the AI Scientist can prevent an AI agent from doing damage. Sandboxing is a security mechanism used to run software in an isolated environment, preventing it from making changes to the broader system:

Safe Code Execution. The current implementation of The AI Scientist has minimal direct sandboxing in the code, leading to several unexpected and sometimes undesirable outcomes if not appropriately guarded against. For example, in one run, The AI Scientist wrote code in the experiment file that initiated a system call to relaunch itself, causing an uncontrolled increase in Python processes and eventually necessitating manual intervention. In another run, The AI Scientist edited the code to save a checkpoint for every update step, which took up nearly a terabyte of storage. In some cases, when The AI Scientist’s experiments exceeded our imposed time limits, it attempted to edit the code to extend the time limit arbitrarily instead of trying to shorten the runtime. While creative, the act of bypassing the experimenter’s imposed constraints has potential implications for AI safety (Lehman et al., 2020). Moreover, The AI Scientist occasionally imported unfamiliar Python libraries, further exacerbating safety concerns. We recommend strict sandboxing when running The AI Scientist, such as containerization, restricted internet access (except for Semantic Scholar), and limitations on storage usage.

Endless scientific slop

Sakana AI developed The AI Scientist in collaboration with researchers from the University of Oxford and the University of British Columbia. It is a wildly ambitious project full of speculation that leans heavily on the hypothetical future capabilities of AI models that don't exist today.

"The AI Scientist automates the entire research lifecycle," Sakana claims. "From generating novel research ideas, writing any necessary code, and executing experiments, to summarizing experimental results, visualizing them, and presenting its findings in a full scientific manuscript."

According to this block diagram created by Sakana AI, "The AI Scientist" starts by "brainstorming" and assessing the originality of ideas. It then edits a codebase using the latest in automated code generation to implement new algorithms. After running experiments and gathering numerical and visual data, the Scientist crafts a report to explain the findings. Finally, it generates an automated peer review based on machine-learning standards to refine the project and guide future ideas.

Critics on Hacker News , an online forum known for its tech-savvy community, have raised concerns about The AI Scientist and question if current AI models can perform true scientific discovery. While the discussions there are informal and not a substitute for formal peer review, they provide insights that are useful in light of the magnitude of Sakana's unverified claims.

"As a scientist in academic research, I can only see this as a bad thing," wrote a Hacker News commenter named zipy124. "All papers are based on the reviewers trust in the authors that their data is what they say it is, and the code they submit does what it says it does. Allowing an AI agent to automate code, data or analysis, necessitates that a human must thoroughly check it for errors ... this takes as long or longer than the initial creation itself, and only takes longer if you were not the one to write it."

Critics also worry that widespread use of such systems could lead to a flood of low-quality submissions, overwhelming journal editors and reviewers—the scientific equivalent of AI slop . "This seems like it will merely encourage academic spam," added zipy124. "Which already wastes valuable time for the volunteer (unpaid) reviewers, editors and chairs."

And that brings up another point—the quality of AI Scientist's output: "The papers that the model seems to have generated are garbage," wrote a Hacker News commenter named JBarrow. "As an editor of a journal, I would likely desk-reject them. As a reviewer, I would reject them. They contain very limited novel knowledge and, as expected, extremely limited citation to associated works."

reader comments

Promoted comments.

Channel Ars Technica

Numbers, Facts and Trends Shaping Your World

Read our research on:

Full Topic List

Regions & Countries

• Publications
• Our Methods
• Short Reads
• Tools & Resources

Read Our Research On:

Harris Energizes Democrats in Transformed Presidential Race

1. the presidential matchup: harris, trump, kennedy, table of contents.

• Other findings: Both Harris and Trump are viewed more favorably than a few months ago
• Voting preferences among demographic groups
• How have voters shifted their preferences since July?
• Harris’ supporters back her more strongly than Biden’s did last month
• Large gap in motivation to vote emerges between the candidates’ younger supporters
• Harris and Trump have gained ground with their own coalitions
• Share of ‘double negatives’ drops significantly with change in presidential candidates
• Views of Biden have changed little since his withdrawal from the 2024 presidential race
• Acknowledgments
• The American Trends Panel survey methodology

Nationally, Vice President Kamala Harris and former President Donald Trump are essentially tied among registered voters in the current snapshot of the presidential race: 46% prefer Harris, 45% prefer Trump and 7% prefer Robert F. Kennedy Jr.

Following Biden’s exit from the race, Trump’s support among voters has remained largely steady (44% backed him in July against Biden, while 45% back him against Harris today). However, Harris’ support is 6 percentage points higher than Biden’s was in July . In addition to holding on to the support of those who backed Biden in July, Harris’ bump has largely come from those who had previously said they supported or leaned toward Kennedy.

Harris performs best among the same demographic groups as Biden. But this coalition of voters is now much more likely to say they strongly support her: In July, 43% of Biden’s supporters characterized their support as strong – today, 62% of Harris’ do.

Overall, many of the same voting patterns that were evident in the Biden-Trump matchup from July continue to be seen today. Harris fares better than Trump among younger voters, Black voters, Asian voters and voters with college degrees. By comparison, the former president does better among older voters, White voters and voters without a college degree.

But Harris performs better than Biden across many of these groups – making the race tighter than it was just a few weeks ago.

• In July, women’s presidential preferences were split: 40% backed Biden, 40% preferred Trump and 17% favored Kennedy. With Harris at the top of the ticket, 49% of women voters now support her, while 42% favor Trump and 7% back Kennedy.
• Among men, Trump draws a similar level of support as he did in the race against Biden (49% today, compared with 48% in July). But the share of men who now say they support Harris has grown (to 44% today, up from 38% last month). As a result, Trump’s 10-point lead among men has narrowed to a 5-point lead today.

Race and ethnicity

Harris has gained substantial ground over Biden’s position in July among Black, Hispanic and Asian voters. Most of this movement is attributable to declining shares of support for Kennedy. Trump performs similarly among these groups as he did in July.

• 77% of Black voters support or lean toward Harris. This compares with 64% of Black voters who said they backed Biden a few weeks ago. Trump’s support is unchanged (13% then vs. 13% today). And while 21% of Black voters supported Kennedy in July, this has dropped to 7% in the latest survey.
• Hispanic voters now favor Harris over Trump by a 17-point margin (52% to 35%). In July, Biden and Trump were tied among Hispanic voters with 36% each.
• By about two-to-one, Asian voters support Harris (62%) over Trump (28%). Trump’s support among this group is essentially unchanged since July, but the share of Asian voters backing Harris is 15 points higher than the share who backed Biden in July.
• On balance, White voters continue to back Trump (52% Trump, 41% Harris), though that margin is somewhat narrower than it was in the July matchup against Biden (50% Trump, 36% Biden).

While the age patterns present in the Harris-Trump matchup remain broadly the same as those in the Biden-Trump matchup in July, Harris performs better across age groups than Biden did last month. That improvement is somewhat more pronounced among voters under 50 than among older voters.

• Today, 57% of voters under 30 say they support Harris, while 29% support Trump and 12% prefer Kennedy. In July, 48% of these voters said they backed Biden. Trump’s support among this group is essentially unchanged. And 12% now back Kennedy, down from 22% in July.
• Voters ages 30 to 49 are now about evenly split (45% Harris, 43% Trump). This is a shift from a narrow Trump lead among this group in July.
• Voters ages 50 and older continue to tilt toward Trump (50% Trump vs. 44% Harris).

With Harris now at the top of the Democratic ticket, the race has become tighter.

Much of this is the result of shifting preferences among registered voters who, in July, said they favored Kennedy over Trump or Biden.

Among the same group of voters surveyed in July and early August, 97% of those who backed Biden a few weeks ago say they support or lean toward Harris today. Similarly, Trump holds on to 95% of those who supported him a few weeks ago.

But there has been far more movement among voters who previously expressed support for Kennedy. While Kennedy holds on to 39% of those who backed him in July, the majority of these supporters now prefer one of the two major party candidates: By about two-to-one, those voters are more likely to have moved to Harris (39%) than Trump (20%). This pattern is evident across most voting subgroups.

In July, Trump’s voters were far more likely than Biden’s voters to characterize their support for their candidate as “strong” (63% vs. 43%). But that gap is no longer present in the Harris-Trump matchup.

Today, 62% of Harris voters say they strongly support her, while about a third (32%) say they moderately support her. Trump’s voters are just about as likely to say they strongly back him today as they were in July (64% today, 63% then).

Kennedy’s voters make up a smaller share of voters today than a month ago – and just 18% of his voters say they strongly support him, similar to the 15% who said the same in July.

Across demographic groups, strong support for Harris is higher than it was for Biden

Among women voters who supported Biden in July, 45% said they did so strongly. That has grown to 65% today among women voters who support Harris.

Increased intensity of support is similar among men voters who back the Democratic candidate: In July, 42% of men voters who supported Biden said they did so strongly. This has since grown to 59% of Harris’ voters who are men.

Across racial and ethnic groups, Harris’ supporters are more likely than Biden’s were to say they back their candidates strongly.

Among White voters, 43% who supported Biden in July did so strongly. Today, Harris’ strong support among White voters sits at 64%.

A near identical share of Harris’ Black supporters (65%) characterize their support for her as strong today. This is up from the 52% of Biden’s Black supporters who strongly backed him in July. Among Harris’ Hispanic supporters, 56% support her strongly, while 45% of Asian Harris voters feel the same. Strong support for Harris among these voters is also higher than it was for Biden in July.

Across all age groups, Harris’ strength of support is higher than Biden’s was. But the shift from Biden is less pronounced among older Democratic supporters than among younger groups.

Still, older Harris voters are more likely than younger Harris voters to describe their support as strong. For instance, 51% of Harris’ voters under 50 say they strongly support her, while 71% of Harris supporters ages 50 and older characterize their support as strong.

Today, about seven-in-ten of both Trump supporters (72%) and Harris supporters (70%) say they are extremely motivated to vote.

Motivation to vote is higher in both the Democratic and Republican coalitions than it was in July .

These shifts have occurred across groups but are more pronounced among younger voters.

Today, half of voters under 30 say they are extremely motivated to vote, up 16 points since July. Motivation is up 11 points among voters ages 30 to 49 and 50 to 64, and up 6 points among those ages 65 and older.

Among the youngest voters, the increased motivation to vote is nearly all driven by shifts among Democratic supporters.

• In July, 38% of 18- to 29-year-old Trump voters said they were extremely motivated to vote. Today, a similar share of his voters (42%) report that level of motivation.
• But 18- to 29-year-old Harris supporters are far more likely to say they are extremely motivated to vote than Biden’s supporters in this age group were about a month ago. Today, 61% of Harris’ voters under 30 say this. In July, 42% of voters under 30 who supported Biden said they were extremely motivated to vote.

Sign up for our weekly newsletter

Fresh data delivery Saturday mornings

Sign up for The Briefing

Weekly updates on the world of news & information

• Donald Trump
• Election 2024
• Kamala Harris
• More Leaders
• Political & Civic Engagement

Many Americans are confident the 2024 election will be conducted fairly, but wide partisan differences remain

Joe biden, public opinion and his withdrawal from the 2024 race, amid doubts about biden’s mental sharpness, trump leads presidential race, americans’ views of government’s role: persistent divisions and areas of agreement, cultural issues and the 2024 election, most popular, report materials.

• August 2024 Presidential Preference Detailed Tables
• Questionnaire

901 E St. NW, Suite 300 Washington, DC 20004 USA (+1) 202-419-4300 | Main (+1) 202-857-8562 | Fax (+1) 202-419-4372 |  Media Inquiries

Research Topics

• Email Newsletters

ABOUT PEW RESEARCH CENTER  Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. It conducts public opinion polling, demographic research, media content analysis and other empirical social science research. Pew Research Center does not take policy positions. It is a subsidiary of  The Pew Charitable Trusts .

© 2024 Pew Research Center